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ABSTRACT
A phage collection (M1114), which is a mixture of two collections, M710-3R
and Silica 426 each derived from a human synthetic phage antibody library (Fab 2lox),
was used further enriched for dextran binding using enzyme-linked immunosorbent
assays (ELISA) screening. The effects of dextran concentration on phage binding affinity
were tested using indirect sandwich ELISA on phage collections, M1114-m74 and AEM1114-m74-2R. Most of the phage bound to dextran (T2000) coated on a sandwich
ELISA. The combination of ELISA screening and a sephadex columns enriched dextran
binding 7 fold over enrichment by a single ELISA screen. Phage collection (M1114-m74)
produced by combination screening showed the greatest binding on ELISA. The color
intensity produced by phage collection (AE-M1114-m74-2R) obtained after the 2nd round
of selection was 3.5 fold higher than that of phage collections, AE-M1114-m74-1R after
the 1st round. Dextran binding by phage collection (AE-M1114-m74-2R) was illustrated
using image analysis of transmission electron micrographs. Sephadex bead agarose
electrophoresis (SBAE) screening produced phage collections (AE-M1114-m74-1R and
2R) which were used in a paper-dip assay. A dip stick assay using a protein blocked
paper with adsorbed high molecular size dextran (T10,000, 107) produced the most color
(59 ±5) using anti-dextran phage enzyme linked assays. Low molecular size dextran
(T40, 4x104) produced significantly lower color (15 ±1). Phage collection (AE-M1114m74-2R) was tested for specificity against dextran (T2000), corn starch, sucrose,
dextrose, and chitin. Dextran produced up to 18 fold the normalized intensity of the other
carbohydrates.
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The presence of Fab inserts in the phage collections was confirmed using PCR,
and the presence of the same insert in the host E.coli was checked using a β-galactosidase
linked assay. DNA sequencing of phage collection (AE-M1114-m74-2R) confirmed that
human origin antibody was present. The PCR products of λ, κ light chains and heavy
chain from phage collection (AE-M1114-m74-2R) were approximately 420 bp, 550 bp
and 600 bp.
This research used various selection methods to isolate anti-dextran phages from
a library. These were used to develop a paper-dip stick method for dextran detection used
for routine screening of sugar juices.

x

INTRODUCTION
Display technology can be used to develop biological reagents with affinity for
specific antigens. Display systems have been studied that use surfaces of phage, yeast,
flagella, Bacillus spores, and Staphylococcal cell walls. Yeast cells expressing cell
receptors on their surfaces can function as antigens, producing T cell activation (Cho, et
al., 1998). Flagella can express small fragments of foreign peptides, inserted in a variable
domain of the E.coli or Salmonella FlicC, without harming flagella function. Due to
strong immune reactions and the adjuvant effect of flagella, a flagella peptide display was
used to produce vaccines against cholera toxin, hepatitis B, influenza A, and HIV-1.
Peptides fused to FliC of E.coli were also used for production of random peptide libraries
and antibodies against lysozyme. Bacillus subtilis spore coat protein gene, cotB, was
modified so as to express foreign proteins, such as tetanus toxin (C fragment) on the
spore surface (Isticato, et al., 2001). Gram positive bacteria such as Staphylococcus
xylosus and Staphylococcus carnosus have been shown to express in a surface display a
mouse immunoglobulin G1(κ) anti-human IgE single chain Fv antibody fragment
(Gunneriusson, et al., 1996).
A phage display antibody library contains all possible antibody fragments as
inserts in a viral coat protein. Use of a library simplifies the process for production of
antibody binding proteins (Harrison et al., 1996 and Clackson et al., 1991). Fd phage is a
filametous phage that can display Fab (antigen binding fragments) as fusion proteins with
pIII, a minor coat protein of the phage. Phages containing the fusion protein with
antibody fragments (Fab) have the ability to bind epitopes (Harrison et al., 1996).
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Antibody fragments expressed on the surface of the filamentous bacteriophage,
fd, can be used as a reagent to detect antigens, tumor cells, virus, and toxins. Numerous
reported applications use Fab fragments (Itoh, et al., 2001), including immunotherapy,
delivery of molecules to kill specific cells, neutralization of HIV-2, vaccine development
and activation of T-cells around tumor cells (Bjorling, et al., 1999, Chames, et al., 2000
and Nilsson, et al., 2000).
Dextrans are high molecular weight poly glucans with α-1,6 linked main chains
and varying degrees of α-1,2 α-1,3, or α-1,4 linked branch chains. It is synthesized
enzymatically from sucrose by dextransucrases, glucansucrases, or glucosyltransferases
produced by Leuconostoc or Streptococcii bacteria (Newman, at al., 1985 and Robyt,
1986). These bacteria growing in sugar juices produce dextran. High concentrations of
dextran on solids (> 1000 ppm) can produce severe financial loss to the sugar industry
(Clarke and Godshall, 1988). Several methods for dextran analysis are currently available
to this industry. They are the Roberts copper method (Clarke and Godshall, 1988), the
alcohol haze test (ICUMSA, 1994), the ASI II method (Sarkar and Day, 1986), the
Optical Activity Ltd. DASA method (Singleton, 2001) and the Midland SucroTestTM
(Day, et al., 2002). Midland SucroTestTM is an immunological method that uses a
dextran specific monoclonal antibody to produce an increase in turbidity. The assay
method is rapid, utilizes a minimum of equipment and highly specific to dextran but the
cost per analysis is considered to be high for bulk screening of agricultural products.
Surface display technology, can extend the analytical options for dextran analysis, in
order to provide a low cost, dextran specific analytical method that can be used for
routine screening of sugar cane.
2

1. LITERATURE REVIEW*
1.1.

Overview of Phage Display Antibody Technology

1.1.1. Filamentous Phages. Filamentous phages, including M13, fd, and f1, are
composed of 6500 bases of circular single-stranded DNA covered by a single layer
containing 2,700 molecules of a single protein (VIII). In addition, four gene products, IV
and VII and III and VI, are located at the distal end of each phage. Filamentous phages
are a convenient vehicle for expressing proteins from cloned DNA, because sequences
can be inserted into sites within gene III, which codes for protein (g3p), without
disrupting functionality of the phage. Between 100-200 phages are discharged from each
infected E.coli cell, but infection is not lethal to the host, it just slows growth (Breitling
and Dubel, 1999). The infection cycle of filamentous phages are shown in Figure 1. The
initial infection is mediated by interactions between the F-pili of E.coli carrying an F
episome and the gene 3 protein (g3p). The N-terminal domain of g3p binds to TolA
proteins in the periplasmic membrane. TolA proteins bring the phages close to inner
membrane where the phage DNA is released to the cytoplasm (Breitling and Dubel, 1999
and Karlsson, et al., 2003).
1.1.2. Phage DNA Replication. After the single-stranded phage DNA (plus strand)
enters the host cell, synthesis of the complementary minus strand begins from an RNA
primer, producing a double-stranded replicative form (RF) DNA (Fig. 2). The RNA
primer is made at a specific site on the plus strand DNA by host DnaG protein or RNA
polymerase and is removed by host DNA polymerase I. The product of gene II, an
endonuclease, nicks the plus strand of RF, allowing synthesis of more RFs via rollingcircle replication.
3
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Portions of this chapter are reprinted by permission of Food Science and Biotechnology

pIV + pVII

pVIII

I. Infection
pVI
pIII

V. Release of phage

F+ pilus
OM
Periplasmic
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II. Release of phage DNA
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IV. Packaging

Rolling circle replication

pV

Phage DNA

III. DNA replication

Figure 1. The infection cycle of filamentous phage. The infection of filamentous phage
is initiated by interaction between F-pilus and gene 3 protein (g3p) in step I, TolA
proteins bring the phages close to the inner membrane where the phage DNA is released
into the cytoplasm in step II, DNA is replicated by rolling circle replication in step III,
phages are packed with coat proteins in step IV, and released in step V. Source: Adapted
from Breitling and Dubel (1999) and Karlsson, et al. (2003). OM (IM), outer (inner)
membrane.
, pIII;
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replicaion
Nick in (+) strand by
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Progeny (+) strand
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Figure 2. DNA replication cycle of filamentous phage.
A double-stranded replicative form (RF) is synthesized from a single-stranded
DNA of phage infecting the host cell by host enzymes (DnaG protein or RNA
polymerase). Synthesis of RFs via rolling-circle replication continues after
nicking the plus strand. After accumulation of RF molecules, the phage coat
proteins coat the DNA at unique packaging sites before it leaks out of the cell.
Source: Adapted from Sambrook, et al. (1989a).
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The free 3’ end of each plus strand serves as a primer for a new plus strand, produced by
the DNA polymerase. As each new plus strand is synthesized, the old plus strand peels
off and is used as a template to synthesize another strand, forming another RF. After a
few RF molecules accumulate, the plus strands displaced by rolling-circle replication are
no longer used as templates. The gene IV product binds to plus strands preventing them
from being further used as templates for RF synthesis, and helps package them into phage
heads. The phage coat proteins bind and coat the DNA at unique packaging sites. Finally
the new phage particles leak out of the cell (Sambrook, et al., 1989a).
1.1.3. Construction of a Phage Display Antibody Library. The technology to produce
a phage display library is based on the molecular genetic work of McCafferty
(McCafferty, et al., 1996). Antibody heavy chains are composed of about 50 VH, D and
JH segments with three hypervariable loops (H1, H2, and H3). Light chains are composed
of about 30 V lambda and about 30 V kappa and J lambda and J kappa segments with
three hypervariable loops (L1, L2, and L3). Total RNA extracts of either human
lymphocytes or spleen cells from immunized mice are used in preparing a phage antibody
library. RNA is isolated by phenol and chloroform extraction followed by ethanol
precipitation. An oligo (dT) column is used to isolate pure mRNA (McCafferty, et al.,
1996 and Davis, et al., 1994). cDNA strands are synthesized from this mRNA using
random hexamer primers, dNTP, reverse transcriptase, and RNasin (a ribonuclease
inhibitor) in a buffer (KCl, Tris-HCl, and MgCl). Expressed Variable genes (VH and VL)
of cDNA or genomic DNA are amplified using polymerase chain reaction with specific
primer sets encoding variable gene or leader sequences and J genes to create gene
collections of variable heavy and light chains (McCafferty, et al., 1996). Thirty one
6

specific primers are required for synthesis of an antibody library from human blood. It
requires six VHBACK and four JHFOR primers for heavy chain genes and six VKBACK
and five JKFOR primers for the kappa light chain genes, and seven JλBACK and three
JλFOR primers for the lambda light chain genes (McCafferty, et al., 1996). After
amplification of the cDNA, the various heavy and light genes which are produced by the
31 primers, make a library. The variable heavy chains and variable light chains are
amplified using primers with specific restriction sites (ApaL1, AscI, SfiI, NotI) and then
digested with ApaL1, AscI, SfiI, and NotI and cloned to vectors (Waterhouse, et al.,
1993). There are several cloning methods available for creating gene collections of heavy
and light antibody including using phagemid vectors, phage vectors, by in vitro
recombination or combinatorial infection and in vivo recombination (Winter, et al.,
1994). Phage vectors contain all the genes required for infection, replication, assembly, a
tetracycline marker and protein III for phage production. A phagemid vector consists of
origin sites for plasmid and phage, an ampicillin marker and needs a helper phage for
replication and packaging of the phagemid (Harrison, et al., 1996).
1.1.4. Producing a Large Antibody Library. Combinatorial infection and in vivo
recombination is used to construct large antigen binding fragment (Fab) repertoires in
gene libraries (Griffiths, et al., 1994). The lox-Cre system (Davies, et al., 1995 and
Griffiths, et al., 1994) is used to produce variable genes by combinatorial infection
between the fd phage vector, fdDOG-2lox and the plasmid vector, pUC19-2lox.
Recombination occurs between the heavy and light chains from the two vectors
(Waterhouse, et al., 1993 and Winter, et al., 1994). The Cre recombinase of
bacteriophage P1 mediates recombination of the loxP site, which consists of two inverted
7

repeats and 8 bp spacers and is flanked by heavy and light genes. DNA sequences from
loxP 511(mutant loxP) and loxP wt (wild type lox P) are present in the 2lox phage vector
DNA sequence (Fig. 3) with a phage fd gene III leader peptide sequence (Lg3), a pelB
leader peptide sequence (LpelB), and a ribosomal binding site (r.b.s.) (Davies, et al.,
1995 and Griffiths, et al., 1994).
The fd phage (fd DOG-2lox vector) is used as a loxP acceptor, encoding the light
chains, and pUC19-2lox as a loxP donor, encoding the heavy chains (Fig. 4). The
variable heavy chains and variable light chains are amplified using primers with specific
restriction sites from antibody cDNA by polymerase chain reaction, and then variable
light chain DNA are cloned to an fdDOG-2lox vector (fd phage) and heavy chain DNA to
a pUC19-2lox. E.coli TG1 infected with fd phage carrying a light chain gene library is
incubated for propagation of the fd phage. Separately, E.coli TG1 is transformed by the
pUC19-2lox carrying the heavy chain gene library, and the culture containing pUC192lox is incubated to produce a log phase culture. The log phase culture is infected with
fdDOG-2lox, containing a variable kappa or lambda gene library and then incubated to
produce the combination of a heavy and a light gene library. Two loxP sites flanked by
the variable heavy chain link the heavy and light chains during combinatorial infection in
host cells. This culture is infected with phage P1, to use its lox-Cre system for in vivo
recombination. Cre recombinase combines a light and a heavy chain gene into an fd
phage vector that encodes Fab fragments expressed on the surfaces of fd phages. From
the resulting recombinants, the fd phage repertoire reaches to 4.1x1013 transducing unit
(t.u.) (Breitling and Dubel, 1999 and Griffiths, et al., 1994).
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GCTGTCTTTCGCTGCTGAGGGTGACGATCCCGCAAAAGCGGCCTTTGACTCCC
TGCAAGCCTCAGCGACCGAATATATCGGTTATGCGTGGGCGATGGTTGTTGTC
Fd-tet-Dog1
ATTGTCGGCGCAACTATCGGTATCAAGCTGTTTAAGAAATTCACCTCGAAAG
CAAGCTGATAAACCGATACAATTAAAGGCTCCTTTTGGAGCCTTTTTTTTTGG
AGATTTTCAACGTGAAAAAATTATTATTCGCAATTCCTTTAGTTGTTCCTTTCT
ATTCTCACAGTGCACAGGTCCtaataaggcgcgccaaagcttccttaatataacttcgtataatgtatactatac
Lg3
ApaL1
loxP 511
loxP
gaagttattaggtcgcatgcaaattctatttcaaggagacagtcataatgaaatacctattgcctacggcagccgctggattgttat
511
r.b.s.
LpelB
actcgcggcccagccggccatggccAACTGCAGGAGCTCGAGATCAAACGGGCGGCCGCcc
Not1
ttaatataacttcgtataatgtatgctatacgaagttattaggtctggcgcaGAAACTGTTGAAAGTTGTTTAG
loxP wt
loxP wt
fd gene III
CAAAACCTCATACAGAAAATTCATTTACTAACGTCTGGAAAGACGACAAAAC
TTTAGATCGTTACGCTAACTATGAG
loxP 511

loxP wt

VL
Lg3

H

gIII

LpelB

ApaLI

NotI

Figure 3. A 2lox vector sequence. A 2Lox Vector was modified from fd-tet-Dog1
[Nucleic Acids Res. 19:4133 (1991)] with altered polylinker sequences and the lox sites
as described in EMBO J, 13:3245 (1994) and Nucleic Acids Res., 21:2265(1993).
Lg3: phage fd gene III leader peptide sequence
LpelB: pelB leader peptide sequence
r.b.s.: ribosomal-binding sites
loxP wt: wild-type loxP
loxP 511: mutant loxP
VL : Light chain gene
H: Heavy chain gene
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cDNA
I. Polymerase chain reaction using primers
with restriction sites
VH genes

VL genes

II. Cloning to LoxP donor
or acceptor vector
VL
VH

LoxP donor (pUC 19-2lox)

LoxP acceptor (fdDOG-2lox)
III-1. Transformation of each phage vector into E. coli
and propagation of fd phage

III-2. Transformation into E.coli

H

IV. Infection of fd phages to E.coli carrying
pUC 19-2lox for combination of light and
heavy chain library
H

L

V. In vivo recombination in E.coli
by Cre recombinase

Phage display library

H

L

Figure 4. Combinatorial infection and in vivo recombination of variable gene
repertories. The variable heavy chains and variable light chains are amplified by
PCR using primers with restriction sites from cDNA (I) and then variable light chain
DNA are cloned to fdDOG-2lox vectors (fd phage) and heavy chain DNA, pUC192lox (II). E.coli TG1 infected with fd phage carrying light chain gene library is
incubated for propagation of the fd phage (III-1) and E.coli TG1 transformed by
pUC19-2lox carrying heavy chain gene library is incubated to produce a log phase
culture (III-2). The log phase culture is infected by fdDOG-2lox containing a variable
kappa or lambda gene library and then incubated for the combination of a heavy and a
light gene library (IV). Cre recombinase combines a light and a heavy chain gene into
an fd phage vector (V). H: Heavy chain and L: Light chain. Circles: recombination
signals. Source: Adapted from Winter, et al.(1994) and Breiling and Dubel (1999).
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1.1.5. Phage Display Antibody Expression Formats. Immunoglobulin G (IgG) consists
of two light chains (VL and CL) and two heavy chains (VH, CH), with complementaritydetermining-regions (CDRs) in the variable domains of the light and heavy chains with
disulfide bridges connecting the light and heavy chains (Fig. 5). Functionally, IgG
consists of Fab fragments where antigen binds (VH, VL, CH1, and CL) and Fc fragments
for complementation activation (CH2) and macrophage binding (CH3) (Breitling and
Dubel, 1999). The display antibody formats are antigen binding fragments (Fab), single
chained fragment variable (scFv), Fragment variable (Fv) and two linked scFv (diabody)
(Fig. 6). To form Fab, light and heavy chains are batched cloned into a phage genome as
a fusion to the gene encoding pIII. Both chains fuse in the periplasmic space, producing
Fab consisting of VH, VL, CH1, and CL on the phage surface (Hoogenboom, et al., 1998).
An Fab was chosen by Chames, et al. (2000) as an alternative to scFv because it
maintains a more stable form after purification and permits the use of CH1 as a tag for
detection and purification of Fab. scFv has a peptide (15-20 residues) that links the
variable domains of the heavy (VH) and light chains (VL). Linker DNA, which has
sequences common to the C terminus of VH and the N terminus of the VL genes, links the
VH and VL genes. These linked variable genes that contain restriction sites are amplified
by primers and then ligated into the phagemid vector. This produces 4 types of libraries,
VHµ-Vκ, VHµ-Vλ, VHγ-Vκ, and VHγ-Vλ (Marks, et al., 1991). The smallest format is
an Fv fragment consisting of only a variable heavy chain. Minibodies are fused formats
with a structure stabilized by linking a CH3 and either an Fab or scFv fragment. They are
used for diagnostic assays (Chames and Baty, 2000 and Nilsson, et al., 2000).
Diabody, triabody and tetrabody are created by linking scFV with short linkers.
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Light chain
CDRs

VL

Heavy chain

VH
CL
CH1
Fab
Hinge region
CH2

Fc
CH3

Figure 5. A schematic structure of an immunoglobulin G. CDRs, complementarydetermining regions; VH, variable region of the heavy chain; VL, variable region of the
light chain; CL, CH1, CH2, and CH3, constant regions; Brown bars, disulfide bonds.
Source: Adapted from Breitling and Dubel (1999).
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VH

VL

CH3

F(ab’)2

IgG

Antigen binding fragment (Fab)

scFV or Fab

CH3

Fragment variable (Fv)
Single chained fragment variable (scFv)

Minibody

)

scFv
scFv

Diabody

Triabody

Tetrabody

Figure 6. Antibody expression formats. Immunoglobulin G (IgG) consists of two
light chains (VL and CL) and two heavy chains (VH, CH), with complementaritydetermining-regions (
) in the variable domains of light and heavy chains and
disulfide bridges (blue lines) that connect the light and heavy chains. Fab consists of
VH, VL, CH1, and CL. scFv has a peptide (red line) that links the variable domains of
the heavy (VH) and light chains (VL). Fv fragment consists of a variable heavy chain.
Minibodies are fused formats with a structure stabilized by linking a CH3 and either an
Fab or scFv fragment. Diabody, triabody and tetrabody are created by linking scFV
using short linkers (black lines and dots).
Source: Adapted from Chames and Baty (2000).
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There can be homobivalent or bispecific scFv fragments in a diabody. A diabody
composed of two identical fragments (scFv) can shows improved binding affinity
(Chames and Baty, 2000).
1.1.6. Phage Display Antibody Selection. The process for selecting and screening for
phage display antibodies is summarized in Figure 7. Isolation of a desired phage from a
phage antibody library (naïve phage library, an immunized phage library or synthetic
phage library) may require a combination of different selection methods, which may
include biopanning, biotinylation, and affinity columns. In biopanning, the phage that
displays the relevant ligand for a specific antigen will be retained in an immunotube,
while non-adherent phage will be washed away. After vigorous washing, bound phage
can be eluted by acid denaturation, reinfected into the host bacteria and re-grown for
further enrichment. ELISA screens are conducted on populations of phage produced at
each round of selection. The binding ability of biotinylated antigens and streptavidine on
magnetic beads can be used in solution, which skips the antigen coating step to a solid
surface, and the antibodies bound to biotinylated antigen are selected by streptavidinecoated magnetic beads. The binding affinity of between antigens and beads of Sepharose
or Sephadex can also be used to select and enrich for a desired antibody (Hoogenboom,
et al., 1998 and Harrison, et al., 1996).
1.1.7. Applications. The expression of antibody on the surface of a filamentous
bacteriophage, fd, provides a rapid method to produce reagents for detection of various
antigens, such as tumor cells, viruses, toxins and carbohydrates. These phages may be
used for both analytical and clinical applications. For example, a phage cloned with antiCD98 gene displayed as an Fab fragment bound to a cell surface containing a CD98
14

Synthesis of various antibody genes
by PCR, combinatorial infection
and in vivo recombination

Immunized or non immunized donors
(Human, Mouse, Rabbit, Chicken, etc)

Immunized phage
library

Naïve phage
library

Synthetic phage
library

Biopanning

Screening of binding affinity

Immunotubes
Affinity chromatography, etc.

ELISA
Paper dip stick
Immunonephelometer

Preparation of various antibody formats
Phage antibody
Antigen binding fragment (Fab)
Single chained fragment variable (scFv)

Figure 7. Summary of phage antibody selection and screening.
Selection of a desired phage antibody from a phage antibody library (naïve
phage library, an immunized phage library or synthetic phage library)
requires multi-biopanning steps to enrich for a desired phage antibody. The
binding to target molecules is screened by immunological methods.
Source: Adapted from Harrison, et al. (1996) and Siegel (2002).
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oncoprotein and produced growth inhibition of tumor cells, indicating a potential
application for immunotheraphy (Itoh, et al., 2001). Phage antibody against tumor
targeting peptides made it possible to locate tumor cells. Phage antibody (scFV or Fab)
fragments fused with carrier molecules, such as toxins, liposomes, radio-labeled markers
or cytokines (IL-2), have been used as vehicles to deliver and capture specific targets, or
kill specific cells, or activate T-cells around tumor cells (Chames, et al., 2000 and
Nilsson, et al., 2000). Glycoprotein 125 bound human Fab fragments were isolated using
phage display technology to neutralize HIV-2 (Bjorling, et al., 1999). Binding of human
display Fab fragments neutralizes virus proteins of rotavirus, measles virus and puumala
hantavirus (Itoh, et al., 1999, Nicacio, et al, 2000 and Nicacio, et al., 2002) making
possible their use in vaccines. Mycotoxins, including zearalenone and fumonisin B1 from
the genus Fusarium, and microcystins of Cyanobacteria, have been studied using phage
display antibodies. Mycotoxin detection technology has now changed to include phage
display technology because of cost (McElhiney, et al., 2000, Yuan, et al., 1997 and Zhou,
et al., 1996).
1.2.

Carbohydrate Binding Antibodies

1.2.1. Phage Display Antibodies with Carbohydrate Binding Affinity. Various phage
display technologies have been developed for selection of antibodies with carbohydrate
binding affinity because it provides a technology to produce antibodies against poorly
immunogenic antigens. Hydrogen bonds and electrostatic properties are considered to be
the primary mode of binding between carbohydrates and proteins, because hydrogen
bonds have higher directional property than van der Waals forces and electrostatic
properties increase binding affinity for polar substrates (Quiocho, 1986). Polar planar
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side chains such as Asn, Asp, Glu, Gln, Arg, and His form hydrogen bonds in sugar
binding sites (Quiocho, 1989).
Variable domains with Fab, scFv or various ligand proteins can be fused with
capsid proteins for display in a phage (Yamamoto, et al., 1999). Mouse origin, Fab-phage
antibody from a phage display library was selected against rhamnogalacturonan by serial
panning enrichment (Williams, et al., 1996). Enhanced binding to Samonella serotype B
O-polysaccharide was produced by a single chain variable fragment (scFv) after sitedirected PCR mutagenesis in the heavy chain changed Ile into Thr (Deng, et al., 1994).
An scFv against cancer cell related-carbohydrate antigens, sialyl Lewisxx and Lewisx has
been used for cancer identification. This library was prepared from human blood donated
from patients (Mao, et al., 1999). Galectin-3 is one of β-galactoside-binding lectins with
a specific binding affinity for galactose and lactose. T7 phage are used for cloning vector
expressing proteins from cloned DNA, where their sequences can be fused with gene X
encoding for capsid proteins. T7 phage displaying capsid proteins fused with galectin-3
showed a binding affinity for galactose and lactose (Yamamoto, et al., 1999 and Yang, et
al., 1998).
1.2.2. Dextran Binding Antibodies. Some dextrans are reported to be antigenic in man.
There are reports of highly branched dextrans causing skin reactions and formation of an
antidextran to native dextran (B742 and B512) produced by Leuconostoc mesenteroides
(Kabat, et al., 1953 and Newman, et al., 1985), although linear dextran is normally
considered to be non-immunogenic. There are also reports of dextran binding antibodies
being found in human, mouse and rabbit antisera (Kabat, et al., 1953, Sharon, et al., 1981
and Outschoorn, et al., 1974). Kabat, et al. (1953) reported that humans injected with 1
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mg of native or clinical dextran produced precipitins and had cutaneous sensitivity to
dextran. Sharon, et al. (1981) obtained antibodies (IgM and IgA) to dextran B512 from
hybridomas of BALB/c and C57BL/6 origin. Rabbit antisera with dextran binding
affinity were formed after immunization with isomaltohexaonic acid coupled to bovine
serum albumin (Outschoorn, et al., 1974). Cisar, et al. (1975) demonstrated differing
degrees of precipitation of BALB/c mouse antibody (IgA), W3129 and QUPC 52 with
dextran. QUPC 52 precipitated with both branched and linear dextran but W3129
precipitated with only branched dextran. A quantitative precipitin assay was used to
determine the type of the antibody binding site to dextran, and mouse monoclonal
antibodies were classified by the type of site (Table 1): “Groove-type” is defined as a
type that binds to unbranched or internal linear or non-terminal sections of α (1-6)-linked
dextran and was produced by “soluble dextran”. “Cavity- type”, bound branched or
terminal non-reducing ends of dextran was produced by “isomaltosyl oligosaccharideprotein conjugates” (Cisar, et al., 1975, Newman, et al., 1985 and Tanaka, et al., 1994).
Dextran B512 is a T cell independent antigen consisting of α (1-6)-linked glucan and is
“groove-type” for antibody binding sites (Tanaka, et al., 1994).
1.3. Dextran Analysis
1.3.1. Dextran. Dextrans are composed of chains of D-glucan (1 to 20 x106) with α-1,6
as the main chain linkage and variable numbers of α-1,2 α-1,3, or α-1,4 branched chain
linkages. Dextran is synthesized from sucrose by dextransucrases, glucansucrases, and
glucosyltransferases, produced by Leuconostoc or Streptococcii (Newman, et al., 1985
and Robyt, 1986). Table 2 shows the different linkage structures found in dextran.
Dextrans of low molecular size (70,000 ± 25,000) are used as blood volume extenders
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Table 1. Immunochemical types of mouse anti-dextran monoclonal antibody
Antibody

16.4.12E

28.4.10A

35.8.2H

36.1.2D

W3129

19.1.2

Strain

C57BL/6

BALB/c

BALB/c

BALB/c

BALB/c

BALB/c

Immunogen

IM6-KLH

IM6-BSA

IM3-BSA

IM3-BSA

Unknown

B512

Isotype

IgA

IgM

IgG1

IgM

IgA

IgM

Type of site

Cavity

Groove

Groove

Cavity

Cavity

Groove

KLH, keyhole limpet hemocyanin; BSA, bovine serum albumin; IM3, isomatotriose;
IM6, isomatohexaose; B512, dextran B512.
Source: Adapted from Matsuda, et al. (1989).
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Table 2. Linkages in different dextrans
Linkages, %
α 1-3Br3

Dextran

Solubility

α 1-6

α 1-3

L.m.B512F

Soluble

95

5

L.m. B742

Soluble

50

L.m. B742

Less soluble

87

L.m. B1299

Soluble

65

L.m. B1299

Less soluble

66

L.m. B1355

Soluble

54

L.m. B1355

Less soluble

95

5

S.m. 6715

Soluble

64

36

S.m. 6715

Insoluble

4

1

2

α 1-2

α 1-4 Br

50
13
35
1
35

94

1

27

11

2

L.m. , Leuconostoc mesenteroides; 2S.m., Streptococcus mutans; 3Br, Branch linkage.
Source: Adapted from Robyt (1986).
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and in blood substitutes (Kim, 1992 and Robyt, 1986). Dextran derivatives, such as
cross-linked dextran (SephadexTM, Phamacia Fine Chemical, Ltd., Uppsala, Sweden),
dextran sulfate, mercaptodextran, and iron-dextran have been used in affinity
chromatography, as anticoagulants, in removal of heavy metals and in treatment of iron
deficiency anemia (Kim, 1992). Dextran (D-glucan) from sucrose produced by S. mutans
is part of dental plaque, providing attachment and protection for S. mutans in the oral
environment. The fructose produced during dextran formation normally is metabolized to
D-lactic acid and the localized acidity causes tooth lesions (Robyt, 1986).
1.3.2. Quantitative Dextran Analysis in the Sugar Industry. Several different methods
are in use for the determination of dextran in the sugar industry. They are Roberts copper
method, ASI II method, the Haze method, Midland SucroTestTM and the Optical Activity
Ltd. DASA method. Roberts copper method determines dextran after polysaccharide
precipitation from sugar solutions by 80% ethanol, and quantitates colorimetrically using
by phenol-H2SO4, after a second precipitation with alkaline copper (II) reagent (Clarke
and Godshall, 1988). The ASI II method, after removal starch by amylase, treats alcoholprecipitated samples with dextranase and α-glucosidase. This results in the conversion of
dextran to glucose. The glucose produced is then quantitated by the Nelson-Somogyi
arsenomolybdate method (Sarkar and Day, 1986). In the alcohol Haze method, dextran is
quantified by determining turbidity at 720 nm, of a 50% alcohol precipitate, after removal
of starch and proteins by amylase and trichloroacetic acid treatment (Day et al., 2002).
These methods, except ASI II, are not specific to dextran and may cross react with other
polysaccharides that may be present. Two newer methods, the Midland SucroTestTM and
the Optical Activity Ltd. DASA methods are reported to determine only dextran. The
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DASA method uses a near infrared spectrometer to detect the change in optical rotation
in a sample prior to, and after dextranase treatment. The dextran concentration is
calculated and displayed as a change in optical rotation in an OA Ltd. SacchAAr 880
polarimeter (Singleton, 2001). The DASA method was reported to give erroneously high
levels of dextran, due to either partial dextran hydrolysis or poor filtration (Singleton,
2001). Midland SucroTestTM is an immunological method that uses a monoclonal
antibody to produce a linear increase in turbidity in response to dextran. The dextran
concentration is determined from the change in turbidity after addition of the sample into
a buffer solution containing a monoclonal antibody and comparing the difference to a
standard. Midland SucroTestTM showed consistent results and a high correlation with the
Haze test with a R2 of 0.8722 (Day et al., 2002). This assay method is a rapid test that
utilizes a minimum of equipment, and is highly specific to dextran, but the cost per
analysis is considered to be too high for extensive use.
1.4. Raw Cane Sugar Processing and Dextran Effects.
Louisiana and Florida produce most of the sugarcane in the US (Table 3). The
impact of the sugar industry on the economy of Louisiana is over $21 billion, it provided
372,000 jobs in 2000 (LMC International Ltd, 2002). The flow diagram for raw cane
sugar production is shown in Figure 8. The first step in processing is the shredding of the
delivered sugar cane by knives and/or shredders. The shredded cane is then milled to
extract juice. This step produces juice and bagasse. The bagasse is used for fuel. The
second step is purification of the juice. Milk of lime is added to adjust the pH of the
extracted the juice to neutrality, followed by flash heating to denature protein, fats, waxes
and gums. Soluble phosphates such as superphosphate, dicalcium phosphate as well as
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Table 3. USDA report on sugar cane production and value in 2000
State
Louisiana

Area
harvested
(,000 acres)
500

Yield
(tons/acre)

Production
(,000 tons)

Price($)
(per ton)

27.6

13,811

20.7

Value of
cane
(million)
285.3

Florida

445

36.8

16,354

24.5

401.2

Texas

46.3

38.1

1,765

23.5

41.6

Hawaii

34.4

68.7

2,364

27.1

64

Total US

1,025.7

33.4

34,294

23.1

792.0

Source: USDA ERS Sugar and Sweetener Situation and Outlook Report, May 2001 and
LMC International Ltd. (2002).
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B
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Figure 8. A flow diagram of raw cane sugar production.
Source: Adapted from Chung (2000).
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polymer flocculants may be used to aid the clarification of the juice. If conditions
warrant, dextranase may be added to the juice to reduce the dextran concentrations. Muds
are removed by defecation and concentrated on rotary drum vacuum filters. The clarified
juice is concentrated by vacuum evaporation. The clarified juice, which contains about
85% water, is concentrated to a 65% solids, 35% water syrup. The final stage is
crystallization. The syrup is evaporated in vacuum pans to super saturation and mixed
with seed crystals to form a massecuite, a mixture of crystals and mother liquor. The
crystals are allowed to grow to commercial size (1.05 mm) by a balancing syrup feed and
water evaporation. The raw sugar is then separated by centrifugation into the mother
liquor and sugar. The crystallization process is repeated three times for a given syrup.
The sugar from the first and second crystallizations are commercial grade. The third
crystallization is the source of seed grain (Chen and Chou, 1993).
Dextran producing bacteria are found in high sucrose areas, including the soil in
sugarcane fields, in sugar juices and on exposed equipment in cane and beet sugar mills
and sugar refineries (Robyt, 1986 and Clarke and Godshall, 1988). The concentration of
dextran found in sugar mill process streams can be greater than 5000 ppm on volume and
750 ppm or higher in sugar. Dextran in process streams can cause production loss by
increasing viscosity, lowering crystallization rate and changing sugar shape. This has
resulted in dextran in sugar of > 250 ppm bringing direct financial penalties to the
producer from the refiner (Clarke and Godshall, 1988). Problems in sugar processing
associated with the presence of dextran include high viscosity, poor filtration, low
evaporation rates, poor crystallization, and slow mud settling. The presence of dextran in
juices is normally indicative of stale cane. Juice from stale cane requires more lime to
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control pH and longer heating treatment in the clarification step (Chung, 2000). High
dextran concentrations also inhibit crystal growth, forming elongated (needles) crystal
and lowering the quality of the sugar. An hour delay in processing delivered cane can
result in as much as a 6.5% reduction in sucrose recovery (Chung, 2000). The presence of
dextran above 250 ppm on solids in raw sugar brings forth penalties from the sugar
refiner (Chung, 2000 and Day, 1992). Effects of dextran in juice are shown in Table 4
(Chung, 2000). Management of dextran problems requires early detection in order to
control quality. There is a need for a rapid, simple, low cost method for dextran analysis
in order to measure dextran in sugarcane as it is delivered to the factory.
1.5. Dip-Stick Assay Systems
Dip stick assays have the advantages of simplicity, rapidity and low cost. Most
dip-stick assays are based on “dot-immunobinding”, which is a basic research tool for
separation of identification of ligands. Clinical diagnostic applications of dip stick tests
have included detection of adenovirus, Chlamydia, influenza A, and B, and Mycoplasma
(Towbin and Gordon, 1984). Willates et al. (1998) showed the specific binding of (1-5)α-L-arabinan by a monoclonal antibody and Sanden et al. (1993) tested a monoclonal
antibody specific to a lipooligosaccharide of Bordetella pertussis in a dot assay. scFv
phage antibody fused with alkaline phosphatase was used to develop color on a
nitrocellulose membrane for the detection of maltose-binding proteins or glutathione Stransferase (Nakayama, et al., 2001). Park et al. (1992) developed the Ciguatect

TM

test

kit to detect ciguatera toxins in fish, using solid phase immunobeads and membrane dipsticks. A dip-stick assay can use any of a range of papers, such as nitrocellulose, cellulose
acetate or polyvinylidene difluoride as supports for antigens. Solid supports currently used
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Table 4. Effects of dextran in juice
Dextran in juice (ppm/Brix)

Effect

0

None

250

1-point loss in molasses purity*

500

2-point loss in molasses purity

750

Production of 250 MAU sugar

1000

Detectable crystal elongation, 5-point loss in molasses
purity

1500

Significant operational problems

3000

Severe problems

*Purity means % sucrose on solids
Source: Adapted from Chung (2000) and Day (1986).
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for immunoassays are listed in Table 5. Blocking buffers such as skim milk, gelatin or
bovine serum albumin may be used to reduce non-specific binding. The primary antibody
that is bound to the specific antigen is detected by a secondary antibody conjugated with
a peroxidase or other color developing system. The color is then developed, in the case of
peroxidase by the addition of ABTS, 2,2'-azino-bis (3-ethylbenzothiazoline-6-sulfonate)
or a 4-chloro-1-naphthol peroxidase substrate (Dewey, et al., 1989, Hawkes, et al., 1982,
Lavanchy, et al., 1990 and Willats, et al., 1998). Enzyme-substrate based color
development is one dip-stick assay format. A paper is dipped into a PBS buffer solution
containing an antigen and then incubated first with the antibody against the antigen, and
then washed with a washing buffer containing a detergent to remove unbound antibody.
The presence of the antibody is detected by application of a second antibody conjugated
to an enzyme and color is developed by addition of substrate (Hawkes, et al., 1982).
The presence of proteins on PVDF membranes can be detected by dyes such as
Amido black, Coomassie Brilliant Blue R-250, colloidal gold and Ponceau S (Harlow
and Lane, 1988). Florescent dye labeling kits can be used to detect antigens using labeled
antibodies. Commercial protein labeling kits (FluoReporter® protein kits) are available to
label proteins such as Fab or monoclonal antibodies with fluorophore and biotin for
staining (Haugland, 1996). Ninhydrin has been used in a histochemical test for keratin
and in chromatography for staining amino acids (Holmes, 1968). Ninhydrin is a dye that
reacts with α-amino groups producing a purple color (Holmes, 1968).
Our approach was to develop a rapid, paper-dip stick assay for dextran detection
in sugar juices using the dextran binding affinity of a phage display antibody.
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Table 5. Solid supports of immunoassays
Support

Form

Binding methods

Nitrocellulose

Membranes,
Microtiter wells

Noncovalent

Polyvinylchloride

Microtiter plates,
Sheets

Noncovalent

Polystyrene

Beads,
Microtiter plates

Noncovalent

Diazotized paper

Sheets

Covalent by free amino
acids

Activated beads

Beads

Covalent by free amino
acids

Protein A beads

Beads

Noncovalent

Source: Adapted from Harlow and Lane (1988).

29

2. MATERIALS AND METHODS
2.1. Human Synthetic Phage Antibody Library
A human synthetic phage-antibody library (Human Synthetic Fab 2lox Library)
was acquired from the Cambridge Center for Protein Engineering, Cambridge,
England. This library contains a large synthetic repertoire, 1.2 x1012, of Fab
fragments. Variable regions of heavy and light chains of Fab fragments are expressed
with the coat protein (pIII) in the fd filamentous phage.
2.2. Organism and Maintenance
E. coli TG1Tr (K12, D(lac-pro), supE, thi, hsdD5/F'traD36, proA+B+, lacIq,
lacZDM15) was acquired from the Cambridge Center for Protein Engineering,
Cambridge, England. This strain was maintained on M9 minimal media agar plates, at
4°C [100 ml of 10X salts (0.22M Na2HPO47H20, 0.22M KH2PO4, 0.09M NaCl, and
5.35M NH4Cl /liter dH2O), 10 ml 20% glucose (filter sterilized), 1ml of 0.1M CaCl2, and
1ml of 1M MgCl2, 50µl thiamine (100µg/ml), 15g agar in 900 ml dH2O at pH 7.0], and
transferred monthly (Sambrook, et al., 1989b). E. coli TG1Tr colonies were transferred
from M9 minimal agar plates to 5 ml of a TY broth medium (16g tryptone, 10g yeast
extract, 5g NaCl/liter and pH 7.4) and incubated overnight at 37°C. To produce working
cultures, the organism was transferred to TY broth and grown at 37°C for 4 hours (A660
0.4) prior to infection with phage.
2.3. Purification of Phage Stock
30 µl of log phase E. coli TG1Tr (106 cfu/ml) was exposed to the 10 µl of phage
library at 37°C for 30 min. Cells were removed by centrifugation at 3300g for 20 min,
resuspended in TY media and incubated overnight at 37°C. The infected cells were
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centrifuged at 3300g for 20 min and stored in a TY-15% glycerol at -70°C, for use as a
phage source. PEG/NaCl (20% polyethylene glycol 6000, 2.5 M NaCl) was mixed in a
1:5 v/v ratio with supernatants of broth culture, obtained after centrifugation of infected
cultures. The mixture was incubated for 1 hr at 4°C to allow for separation of phages.
Then the PEG/NaCl supernate mixtures were centrifuged at 10,800g, for 30 min, and the
pellets resuspended in phosphate-buffered saline (PBS) (0.13M NaCl, 0.02M Na2HPO4
anhydrous, 0.01M NaH2PO4·2H2O per 1 liter, pH 7.2). After recentrifugation, at 3,300 g
for 10 min, cell free phage solutions were transferred to new tubes and stored in 15%
glycerol in PBS at -70°C.
2.4. Titering Phages
Filamentous phages (Fd, M13, F1) are non-lytic and do not form clear plaques.
Transducing units (t.u.) of phages were obtained by counting phage infected E.coli
TG1Tr colonies growing on TYE (15g agar, 8g NaCl, 10g tryptone, 5g yeast extract/liter)
+12.5 µg/ml tetracycline (tet) plates. Phages solutions were titered by diluting with TY
and incubating with log-phase E.coli TG1Tr at 37 °C for 30 min and then plating on
TYE+tet plates (Zacher, et al., 1980 and Medical Research Council, 1995).
2.5. Selection of Phage Display Antibody
Phages with dextran binding affinity were selected using five different screening
methods; thin layer chromatography (TLC), Sephadex columns, enzyme-linked
immunosorbent assays (ELISA), a combination of ELISA and Sephadex column and
Sephadex bead agarose electrophoresis (SBAE). The dextran binding of phages enriched
by each selection was determined by an immunonephelometric assay and confirmed
using paper chromatography and indirect sandwich ELISA.
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2.5.1. Selection by Thin Layer Chromatography. Dextran (T2000, 2µl volumes of
1000 ppm) was streaked in two discrete bands, on silica plates (UniplateTM Silica gel GF,
10x20cm, Analtech., Inc.). After drying at room temperature, each silica plate was
spotted with 5 µl of phage library solution (108 t.u./ml), below the lower dextran band,
and then developed for 9 min using PBST (PBS + 0.2% Tween 20, Amresco, Solon, OH).
Each dextran containing band on the silica plate was removed by scraping. The removed
portion of silica gel was suspended in 600 µl of PBS to desorb non-attached phage. This
supernatant, which contains unbound phage, was discarded. Phage adsorbed to 15 mg of
silica gel was then desorbed by washing the gel with 500 µl of 100 mM triethylamine
(TEA, pH 10.5) for 3 min, followed by the addition of 250 µl of 1 M Tris-HCl to return
the pH to 7.4. Then 200 µl of TEA/Tris-HCl containing phage was used to infect 20µl of
E.coli TG1 (106 cfu/ml), which was then plated on TYE with tetracycline. The plates
were harvested and the phages produced by these cells were purified from cell pellets
using PEG/NaCl as described above.
2.5.2. Selection by Sephadex Column. Sephadex columns were used to select clones of
interest based on the following procedure (Medical Research Council, 1995). Phage
library solution (100 µl of 108 t.u./ml) was applied to a column containing 10 ml of
Sephadex-50G (Phamacia Fine Chemical, Ltd., Uppsala, Sweden). This column was
eluted with 100ml of PBST (PBS + 0.05% Tween 20) followed by 100 ml of PBS. 1 ml
of triethylamine (100 mM) was added to the column to elute bound phages and then 1 M
Tris-HCl (pH 7.4, 0.5 ml) was used to neutralize the triethylamine in the eluted samples.
30 µl of E.coli TG1-Tr, in log phase, was infected with phage eluted from these columns.
After centrifugation of the infected cultures, at 3,300 g for 10 min, the bacterial cell pellet
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was resuspended in TY and plated on TYE with tetracycline (12.5µg/ml). Following
overnight incubation at 37°C, the colonies on each plate were harvested by washing with
3 ml of TY. They were then incubated for enrichment of phage in 1 liter volumes of TY
with tetracycline (12.5µg/ml). Phage was purified from enrichment cell pellets by
addition of PEG/NaCl, using the method described for purification of phage stock.
2.5.3. Selection by ELISA Screening. ELISA plate wells were coated with 200 µl of
anti-dextran antibody solution (1 vial antibody/10ml PBS, Midland M9010 MCA
antibody, mouse origin, Midland Research Laboratories, Inc., Lenexa, KS) and incubated
overnight at 4°C. They were then blocked with 200 µl of 1% BSA per well for 1h. After a
single washing of the plates with 200 µl of PBS, a suspension of 100 µl dextran (T2000,
10,000 ppm) was added to each well for 2 hours and then washed once with 200 µl of
PBS. This was followed by addition of 100 µl of phage (108 t.u./ml). The ELISA plate
wells were washed 40 x 200 µl of 0.01M sodium phosphate (pH 7.3), a low ionic strength
washing buffer (Maruyama et al., 1994). Then 100 µl of E.coli TG1Tr (A660 0.2) was
added to each washed well, and incubated for 30 min at 37 °C to allow infection. The
infected cell pellets were resuspended in 100 µl of TY+ tetracycline, and plated onto
TYE+tetracycline and incubated overnight at 37 °C. Tetracycline resistant colonies were
randomly chosen from the plates and each was inoculated into 600 µl of TY+tetracycline
and incubated overnight at 37 °C. Phage supernatants from TY+tetracycline cultures
were used to test binding of phage clones to dextran.

33

2.5.4. Selection by Sephadex Bead-Agarose Electrophoresis (SBAE). Phages (10 µl of
107 t.u./ml), m74 were selected by the methods previously described and then was mixed
with 100 µl of Sephadex-50G (SD) beads, for 3 hours at room temperature. Agarose gels
(0.3%) were prepared and 50 µl of treated SD beads were loaded in each well positioned
in the center of the gels. After electrophoresis at 70 volts for 30 min, the SD beads were
collected from the wells, washed three times with 100 µl each of distilled H2O. Phage
adsorbed to SD beads were desorbed by washing the gel with 500 µl of 100 mM
triethylamine (TEA, pH 10.5) for 3 min, followed by the addition of 250 µl of 1 M TrisHCl to return the pH to 7.4 and then the phage (30 µl) elutate was incubated for 30 min at
37°C with E.coli (30 µl, A660 of 0.4) and plated on TYE+tet, which was incubated
overnight at 37°C. The plates were harvested and the phages produced by these cells
were purified from cell pellets using the PEG/NaCl as previously described. These
phages were used for DNA sequencing analysis and characterization of dextran binding
using an indirect sandwich ELISA and a paper-dip assay.
2.6. Confirmation of Presence of an Fab Inserts in Phage
2.6.1. Confirmation of an Fab Insert in a Phage Vector by β-Galactosidase Assay.
E. coli TG1Tr was inoculated into 1ml of LB (Luria-Bertani medium, 10g bactotryptoneTM, 5g bacto-yeast extractTM, 0.17M NaCl per liter, pH 7.0) and incubated at 37
°C for 4 hours. Tubes containing 3ml of top agar (10g bacto-tryptoneTM, 5g bacto-yeast
extractTM, 0.09M NaCl, 8g agar per liter at pH 7.0) were prepared and held at 55 °C. Ten
fold serial dilutions in LB of 10 µl phage stock containing supernatants were dispensed to
the top agar tubes, E. coli TG1 (50 µl) was added into each tube and mixed well. Then 40
µl of a solution of X-gal (5-bromo-4-chloro-3-indolyl-β-D-galactoside, 20mg/ml, Sigma,
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St. Louis, MO) in DMF (dimethylformamide, Sigma) and 4 µl of a solution of IPTG
(Isopropylthio-β-D-galactoside, 200 mg/ml, Sigma, St. Louis, MO) were added to the top
agar tubes and the tubes dispensed to LB agar plates. These were left at room temperature
for 5 min to solidify, and then incubated overnight at 37°C. Samples with an insert DNA
within the pIII were visually colorless, whereas, samples without the insert produced blue
colonies after 12 to 20 h.
2.6.2. Confirmation of an Fab Insert in Phage Vector by PCR. Template DNA was
obtained from phage infected bacterial stocks using a Wizard Plus Mini-preps DNA
purification system (Promega Coporation, Madison, WI) using the manufacturers
recommended procedures. Fab DNA amplification was conducted at 94°C, with 5min for
pre-soaking, followed by 30 cycles of 94°C, 1 min for denaturation, 60 °C, 1 min for
annealing, 72°C, 1.5 min for extension and finished by incubation at 72 °C for 5min in 50
µl of PCR reaction mixture. This PCR mixture consisted of two primers, ten pmole/µl of
Fdpcrback-1 (GCGATGGTTGTTGTCATT, 18mer, Tm 56°C, GC 56%) and ten
pmole/µl of Fdseq1Forward (CCTCATACAGAAAATTC, 17mer, Tm 50.3°C, GC
35.2%), mini-prepped DNA, 5mM of dNTP (GibcoBRL/Life Technologies, Grand
Island, NY), 25mM MgCl (GibcoBRL/Life Technologies, Grand Island, NY), Pfu
polymerase (2.5 U/µl, Stratagene, La Jolla, CA) and 10x Cloned Pfu DNA polymerase
reaction buffer (Stratagene, La Jolla, CA) or Taq polymerase (5U/µl, Applied
Biosystems, Foster City, CA) and 10x Taq PCR buffer (Applied Biosystems, Foster City,
CA). The PCR products were separated by electrophoresis at 70 volts for 60 min on 0.8
% agarose gels using Tris-acetate/ethylenediamine tetraacetic acid electrophoresis (TAE)
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buffer (pH 7.2, 0.04 M Tris base, 0.02 M sodium acetate•3H2O, 0.001 M
Na2EDTA•2H2O per liter).
2.7. Determination of Binding Affinity using ELISA
2.7.1. Indirect Sandwich ELISA. ELISA plate wells (Micro test III flexible assay plate,
Falcon, Becton Dickinson, Franklin Lakes, NJ) were coated with 200 µl per well of antidextran polyclonal antibody (Midland M9010 MCA antibody, Midland Research
Laboratories, Inc., Lenexa, KS) and incubated overnight at 4°C. Then the ELISA plates
were washed once with PBS and then dextran (T2000, 500 ppm, 200 µl/well) was added
to the ELISA plates. MPBST (PBS+0.05% Tween+2% skim milk, 100µl) was added to
control wells. The plates were incubated for 2 hr at 37 °C. After one wash with 200 µl of
PBST (PBS + 0.05% Tween 20), these plates were blocked using 200µl of MPBST per
well for 2 hr at 37°C and then washed twice with PBST. Phage samples (50µl/well) and
2% MPBST (50µl/well) were added each well and incubated for 2 hr at room
temperature. After washing three times with PBST, 100 µl of a dilution (1: 10,000) of
horseradish peroxidase anti-M13 antibody conjugated (HRP-anti-M13, Amersham
Pharmacia Biotech Inc., Piscataway, NJ) in 2% MPBST was added to each wells and
incubated for 90 min at room temperature, and then the wells were washed three times
with 200 µl of PBST. Then 100 µl of a substrate solution containing 500 µg/ml 2,2’azino-bis 3-ethylbenthiazoline-6-sulfonic acid (ABTS, Sigma, St. Louis, MO), 4 µl of
30% hydrogen peroxide in 12 ml of 0.1 M citrate buffer (pH 3.8) was added to each plate
wells, incubated for 10 min at room temperature, and ELISA plates were read using a
SPECTRAmax Plus microtiter plate reader (Molecular Devices Coporation, Sunnyvale,
CA) at A430 (Chung et al, 1990).
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2.7.2. Optimization of ELISA. The optimization of ELISA was performed according to
the methods of Chung et al. (1990). After coating wells overnight at 4°C with 200 µl of
anti-dextran polyclonal antibody, plates were washed once with 200 µl of PBS. Dextran
(T2000), 1.4, 6.3, 25, 100, or 200 µg per well was added to ELISA plates for 2 hours. The
plate wells were washed with 200 µl of PBST, and then blocked with 200µl per well of
2% MPBST for 2 hr at 37 °C. After the wells were washed twice with PBST, phage (10
µl of 105 t.u./ml) was added to each plate well and then they were filled with 90 µl of 2%
MPBST and incubated for 90 min at room temperature. The plate wells were washed
twice with 200 µl of PBST and color was developed by the procedure described
previously.
2.8. Determination of Dextran Binding Using Paper Chromatography
Paper chromatography was used to determine dextran binding of phages using
HRP-anti-M13 and 3,3’,5,5’-tetramethylbenzidine (TM) BlueTM substrate (Intergen
company, St. Milford, MA) for blue color development. Phages (5 µl of 4.4 x 107 t.u./ml)
were mixed with 5µl of a 1000 ppm solution of T2000 at room temperature for 10 min
and 1 µl of the mixture of phages and dextran was spotted on cellulose acetate paper. The
paper was chromatographed with a solvent of 5% skim milk and 0.3% Tween 20 for 15
min. After drying, the paper was treated by spotting 0.5 µl of HRP-anti-M13 on the
origin. The paper was replaced into a chamber containing a fresh solvent for 15 min and
dried at room temperature. The paper was then dipped into a solution containing TM
BlueTM substrate for development of color, which was scanned by NucleoTech's (San
Mateo, CA) NucleoVision scanning densitometry system with GelExpert software. The
normalized intensity was calculated as scanned intensity divided by area of the blot.
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2.9. Determination of Dextran by Immunonephelometric Assay
A dextran solution (600 µl, T2000) was diluted 1 to 1 with distilled water and the
suspended solids were removed either by centrifugation at 12,000 rpm for 10 min, or by
filtration through a membrane filter (0.45 µm pore size, Gelman Coporation, Ann Arbor,
MI.). Measurements of dextran concentrations in samples were performed according to a
modification of the procedure described for the MCA-SucroTestTM, where the initial
reading (No) of 1200 µl antibody solution (600 µl of phage antibody in 600 µl of PBS
buffer) was recorded, then 12 µl of dextran solution was added to the 1200 µl of phage
antibody solution. After mixing, the turbidity (N) was read for 60 min and the differential
(∆ N) was measured. The differential (∆ N) obtained by subtracting the No value from the
reading (N) obtained was a measure of the dextran in the solution. The concentration of
dextran was calculated by comparison with a standard run at the same time.
2.10. Paper-Dip Stick Assay
Polyvinylidene difluoride membranes (PVDF, 0.45 µm pore size, Gelman
Coporation, Ann Arbor, MI.) were used to make paper strips (2cm x 0.5cm). In order to
block nonspecific phage antibody binding sites on the strips, they were dipped into either
10% MPBS (PBS + 10% skim milk) or 10% BSA (Bovine serum albumin) and dried.
The strips were dipped into sugar solutions containing dextran and dried at room
temperature. Then 5 µl of a predetermined concentration of phage was applied to the
paper, incubated for 1 min, and then washed once by dipping in 1% PBST (PBS + 1%
Tween 20). After drying at room temperature, the strips were incubated with 1µl of a
dilution (1: 10000) of HRP-anti-M13 in 5% MPBST (PBS + 1% Tween 20 + 5% skim
milk) for 5 sec and then washed three times by dipping into 1% PBST. The paper was
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developed with 0.5 ml of TM BlueTM substrate, which produced a blue colored spot if
dextran was present. The intensity of the spots was determined by scanning densitometry
using NucleoTech's (San Mateo, CA) NucleoVision with GelExpert software. The
normalized intensity was calculated as scanned intensity divided by area of the blot. A
diagram of the dip assay step is shown in Figure 9.
2.11. Transmission Electron Microscopy (TEM)
The binding of phage to dextran was visualized by TEM by modification of the
method of Derrick and Brlansky (1976). Copper TEM specimen grids coated with
collodion and carbon were placed on for 5 min drops (10 µl) of anti-dextran antibody
from mouse origin, diluted 1:500 with sterile distilled water. Excess anti-dextran
antibody was washed of the grids by touching each to 10 µl drops of distilled water,
twice. The copper TEM specimen grids were then placed for 1 min on drops (10 µl) of
dextran (T10, 500 ppm) dissolved in filtered water, air dried for 5 minutes, blotted with
filter paper to drain excess solution, then touched to a 20 µl drop of test or control phage
(Fab 2lox library) solution (105 t.u/ml) and rinsed once with filtered water. The grids
were exposed to 50 µl of 2% uranyl acetate negative stain, wicked off and then imaged
with a JEOL 100CX TEM operating at 80KV (The Socolofsky Microscopy Center,
Louisiana State University at Baton Rouge, LA). Test or control phage (Fab 2lox library)
were quantitated by counting phages per µm2 TEM images obtained from forty eight
fields on 8 grids. Control phage (Fab 2lox library) was used to calculate the degree of the
non-specific binding on the copper TEM grids coated with dextran.
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Figure 9. A diagram of a paper-dip stick assay.
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2.12. Sequencing of Fab Genes
The PCR products of the κ or λ light chain antibody were amplified from phage
(AE-M1114-m74-2R) by Taq polymerase using Cκ.lib.seq (Light constant kappa chain
library sequence) primer and LMB3 (Laminin β-3) primer for kappa chain and Cλ.lib.seq
(Light constant lambda chain library sequence) primer and LMB3 primer for lambda
chain. These PCR products were combined in a cloning vector (pCR 2.1 TOPO®,
Invitrogen, Carlsbad, CA) for ligation and then used to transform E.coli. A map of the
cloning vector, pCR 2.1 TOPO®, is shown in Figure 10. Plasmid DNA was prepared by
the method of Sambrook et al. (1989c). The PCR products of heavy chain antibody were
amplified by Pfu polymerase using primers, CH1.lib.seq (Heavy constant chain library
sequence) primer and pelBback (Leader peptide of the pectate lyase backward) primer.
DNA sequencing analysis of κ, λ light chains and heavy chain were performed using a
API PRISM 377 DNA sequencer (PerkinElmer, Wellesley, MA) with the following
primers, T7 promoter primer (Invitrogen, Carlsbad, CA) for kappa chain and lambda
chain and CH1.lib.seq for heavy chain (Division of Biotechnology and Molecular
Medicine, School of Veterinary Medicine, Louisiana State University at Baton Rouge,
LA). The primer sequences for PCR and DNA sequencing are shown in Table 6.
2.13. Statistical analysis
Means and standard deviation were used for data comparison. R2, the coefficient
of variation was used to describe fit of the regressions.
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Table 6. Primer sequences for PCR and DNA sequencing
Primer

Sequences

Cκ.lib.seq

5’CAACTGCTCATCAGATGGCG

LMB3

5’CAGGAAACAGCTATGAC

Cλ.lib.seq

5’GTGGCCTTGTTGGCTTGAAGC

CH1.lib.seq

5’GGTGCTCTTGGAGGAGGGTGC

pelBback

5’GAAATACCTATTGCCTACGG

T7 promoter primer

5’TAATACGACTCACTATAGGG
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Figure 10. A schematic map of pCR® 2.1-TOPO® cloning vector.
Source: Invitrogen catalog (2002).
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3. RESULTS
3.1. Pathway for Selection of Dextran Binding Phages and Phage Histories
The pathways for selecting dextran binding phages are summarized in Figure 11.
Dextran binding phages were selected from an Fab 2lox phage library using
combinations of five methods: thin layer chromatography (TLC), sephadex column,
ELISA screening, sephadex column followed by ELISA (or combination of ELISA and
sephadex column) and Sephadex bead-agarose electrophoresis (SBAE). Phages (Silica
426) were selected using TLC; phages (M710-1R and M710-3R) were selected from
sephadex columns and phages (SD-1, 2, 3, 4, 5 and 6) were randomly chosen from plates
of phages M710-3R. Phages, M1114 (a mixture of phages, Silica 426 and M710-3R)
were screened for dextran binding using ELISA. Phage (M1114-89) was randomly
chosen from those selected by ELISA and was further screened using a sephadex column,
producing a high dextran affinity phage collection, M1114-m74. Phage (M1114-m74)
then panned using sephadex bead-agarose electrophoresis, from which phages (AEM1114-m74-1R and AE-M1114-m74-2R) were selected. Phage (AE-M1114-m74-2R)
was the organism of choice for use in a paper dip stick assay.
3.2. Selection of Dextran Binding Phages by Thin Layer Chromatography
As dextran binding phages bind to dextran adsorbed on the silica, thin layer
chromatography was used to select dextran binding phages from the phage display
library. A band of dextran on the TLC plates prevented those phages which bind dextran
from migrating up the plate. Phages that were found absorbed on the dextran sections
(lower and upper) were collected and their dextran binding ability tested using an
immunonephelometric

assay

(Fig.12).
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Fab 2lox phage library

TLC

Sephadex column
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Figure 11. Summary of selection pathway and history of dextran binding phage
selected from human synthetic Fab 2lox library. Five different methods were used to
select a dextran binding phage from the Fab 2lox phage library. They were thin layer
chromatography (TLC), sephadex column, ELISA screening, a combination of ELISA
screening and sephadex column, and sephadex bead-agarose electrophoresis.
, selected phages;
, selection methods.
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Figure 12. Immunonephelometric assay for determination of the
dextran binding affinity of phages recovered from dextran bands on
silica plates. Dextran (2µl volumes of 1000 ppm T2000) was streaked in
two discrete bands, an upper and a lower section on silica plates. The bands
were 1.5 cm apart. Each silica plate was spotted with 5 µl of phage library
solution (108 t.u./ml), 1 cm below the lowest dextran band, and developed
with PBST for 9 min. The dextran bands were removed by scraping. Phage
adsorbed to silica gel was then desorbed by washing the gel with 500 µl of
100 mM triethylamine (TEA, pH 10.5) for 3 min, followed by the addition
of 250 µl of 1 M Tris-HCl to return the pH to 7.4. Phages that were found
in dextran adsorbed sections were collected and their binding tested using
an immunonephelometric assay. The assay measures light scattered by the
lattice complex formed by dextran and phages and is based on the MCASucroTestTM. ∆Turbidity (∆ N) was calculated by subtracting the initial
reading (No) from the reading (N) obtained with dextran in the phage
solution. The error bars represent standard deviation of triplicate
experiments. R2, the coefficient of determination represents of how well
the regression model predict the dependent variables from the independent
variables.
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measured light scattered by lattice complexes formed between dextran and phages
(Whicher, et al., 1983). It is based on the MCA-SucroTestTM. The initial reading (No) of
the anti-dextran test solution was recorded, then 12 µl of solution containing dextran
(T2000, 500 ppm) was added. After mixing, the turbidity (N) was determined after 60
min and the differential (∆ N) calculated by subtracting the No value from the end
reading (N). Phages (Silica 426) collected from the lower dextran section from TLC
plates produced a 21 fold increase in turbidity over phage on upper band. The turbidity
increase was linear with time over 60 min.
3.3. Selection of a Dextran Binding Phages by Sephadex Columns
To enrich for dextran binding, three sequential column selections were performed
on the same phage preparation. Dextran binding was monitored by immunonephelometric
assay using Fab 2lox library as control. M710-1R and M710-3R are the phage
preparations isolated from the first and third round selections (Fig. 13). M710-3R
produced a 5.4 nephelos turbidity unit (NTU) difference (∆N) after 60 min, 2.2 fold
higher than M710-1R, the phage preparation from the first round of selection. M710-1R
and M710-3R, respectively, produced 12 and 27 fold higher turbidities than the control,
Fab 2lox library. A rapid turbidity increase was shown for 10 min. After 10 min, nonlinear turbidity rate continued to increase for 60 min. The formation of turbidity produced
by light scattering will reach to equilibrium and decrease because the size of dextran and
antibody complex will increase and precipitate (Lente, 1997). Enrichment of dextran
binding phage with sequential column selections was not linear with repeated selection.
A rapid improvement in dextran binding was seen with the first selection, with
decreasing increments seen with further repetition.
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Figure 13. Immunonephelometric assay of phage preparation selected
using Sephadex column. Phage library solution (100 µl of 108 t.u./ml) was
applied to a column containing 10 ml of Sephadex-50G and phages binding to
the column were collected. M710-3R, a phage isolated from the third round
of selection showed a 5.4 nephelos turbidity unit (NTU) differences (∆N)
after 60 min, a 27 fold higher value than control, Fab 2lox library and M7101R, the phage preparation from the first round selection, a 12 fold higher than
control in immunonephelometric assay, which measures turbidity using
scattered light of the lattice complex formed by dextran and phages using an
MCA-SucroTestTM. ∆Turbidity (∆ N) was calculated by subtracting the initial
reading (No) from the reading (N) obtained to measure the dextran in the
solution. The error bars represent standard deviation of triplicate experiments.
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Phages may lose their inserts (Fab) during propagation. Phages without inserts
will propagate more rapidly than those with inserts, enriching them in the population,
hence causing an overall reduction in dextran binding affinity. Six E.coli TG1Tr colonies
infected with phage preparation (M710-3R) were chosen from TYE+tet plate grown
colonies and propagated. Phages from these randomly selected colonies were separately
collected (SD-1, SD-2, SD-3, SD-4, SD-5, and SD-6). After PEG/NaCl concentration,
phage preparation of identical concentration was tested for dextran binding (Fig. 14). The
presence of phages that bound to dextran on cellulose acetate paper chromatography was
determined by treatment with HRP-anti-M13 and TM BlueTM substrate, which produces a
blue color. It was quantitated by scanning densitometry. This system compares the color
density of interest with one chosen from the background of the paper. Dextran binding
phages bound to the dextran deposited area on the cellulose acetate paper separating then
from the non-binding phages. The six isolated phages produced different color densities,
indicating different levels of dextran binding phage were present. The normalized
intensity was calculated as scanned intensity divided by area of the blot. Two-thirds of
the phages selected, SD-1(lane 1), SD-2 (lane2), SD-3 (lane 3) and SD-4 (lane 4) showed
higher normalized intensities (N.I.) than the control (-2 N.I.). The control was below the
color density of the background paper. The color densities of SD-5, and SD-6 were below
2 (N.I.) and were considered to be non-specific phages.
3.3.1. Characterization of Phage SD-3. A paper-dip assay was developed using SD-3.
Protein coated paper (PVDF membranes) was dipped into dextran solution (T2000, 1000
ppm) and dried at room temperature. Then 5 µl of a predetermined concentration of
phage was applied to the paper, incubated for 1 min, and then washed once by dipping in
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Figure 14. Determination of dextran binding by phages, SD-1, 2, 3, 4, 5, and
6 on cellulose acetate paper chromatography. Phages (5 µl of 4.4 x 107 t.u./ml)
were mixed with 5µl of a 1000 ppm solution of T2000 at room temperature for
10 min and 1 µl of the mixture of phages and dextran was spotted on cellulose
acetate paper. The paper was chromatographed with a solvent of 5% skim milk
and 0.3% Tween 20 in 100 ml for 15 min. After drying, the paper was treated by
spotting a 0.5 µl HRP-anti-M13 on the origin. The paper placed into a chamber
for 15 min containing a fresh solvent, 5% skim milk and 0.3% Tween 20 in 100
ml. The paper was then dipped into a solution containing TM BlueTM substrate
for development of color, which was scanned by NucleoTech's (San Mateo, CA)
NucleoVision scanning densitometry system with GelExpert software and density
increase was calculated by comparison of color density with the background. (A)
In the paper chromatogram: lane 1 is SD-1; lane 2, SD-2, Lane 3, SD-3; lane 4,
SD-4; lane 5, SD-5; Lane 6, SD-6; C, control (no phage). (B) Comparison of
normalized intensities produced by phages (SD-1, 2, 3, 4, 5, and 6). A color
increase of < 2.0 was taken as no increase.
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1% PBST (PBS + 1% paper, incubated for 1 min, and then washed once by dipping in
1% PBST (PBS + 1% Tween 20). After drying at room temperature, the strips were
incubated with 1µl of a dilution (1: 10000) of HRP-anti-M13 in 5% MPBST (PBS + 1%
Tween 20 + 5% skim milk) for 5 sec and then washed three times by dipping into 1%
PBST. The paper was developed with 0.5 ml of TM BlueTM substrate. The intensity of
the spots was determined by scanning densitometry using NucleoTech's (San Mateo, CA)
NucleoVision with GelExpert software. The normalized intensity was calculated as
scanned intensity divided by area of the blot. The effects of the phage concentration,
dextran concentration, and dextran molecular size on dextran binding affinity on the dip
assay were studied.
To determine the effects of the phage concentration on the amount of dextran
bound, two concentrations of SD-3 (4.4 x 105 titration unit, t.u./ml and 4.4 x 107 t.u./ml)
were prepared. The normalized intensities produced by the phage preparations on a paper
dip assay were 62±7.7 N.I. and 72±20 N.I., respectively, against 1000 ppm dextran,
indicating saturation at phage concentrations above 4.4 x 105 t.u./ml. For dextran
concentration determinations, a dextran solution (T2000, 5000 ppm) was diluted with
PBS to make 10, 100, 500 and 1000 ppm solutions. Test solution (5 ml) was absorbed to
each paper strip to give 0.15, 1.5, 7.5 or 15µg of dextran. The detection of dextran was
tested using phage SD-3 (4.4 x 107 t.u./ml). The highest normalized intensity was found
with 500 ppm of dextran (T2000, 7.5 µg), which showed 89±6 N.I. There was no increase
in normalized intensity with higher concentration, possibly due to blinding of the
substrate or a limitation in the dextran binding capacity of the paper (Fig. 15). The linear
region appears to be between 0 – 200 ppm dextran. The normalized intensity in this assay
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Figure 15. The effect of dextran (T2000) concentration on detection using a
paper-dip assay with phage (SD-3). (A) Dextran (T2000, 5000 ppm) was
diluted with PBS to make 10, 100, 500, and 1000 ppm and dextran solution (5
ml/paper) was applied to each paper to give 0.15, 1.5, 7.5 or 15µg of dextran.
The presence of dextran was tested in the paper dip assay using phage (SD-3,
4.4 x 107 t.u./ml). Horse radish peroxidase anti-M13 antibody conjugated and
TM BlueTM substrate produced blue color. (B) The blue color of a paper-dip
assay was scanned by NucleoTech's (San Mateo, CA) NucleoVision scanning
densitometry system with GelExpert software. The error bars represent standard
deviation of triplicate experiments (n = 6).
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increased as the molecular size of dextran increased. The normal intensities of a 500 ppm
test dextran solution, 7.5 µg of dextran on the paper of T10 (104), T40 (4 x 104), and
T2000 (2 x 106) were 30±6, 40±6, and 72±10 N.I., respectively (Fig. 16). The detection
of dextran was linear with the log of the molecular size and the detectability of high
molecular weight (T2000) was about 2.5 times higher than for low molecular weight
(T10).
3.4. Selection by ELISA Screening
A new phage collection (M1114) was prepared by mixing phage collections
M710-3R and Silica 426. This was used for selection by ELISA. This collection (M1114)
was screened for dextran binding using ELISA plates, coated with anti-dextran
polyclonal antibody (Midland M9010 MCA antibody) followed by dextran T2000.
Ninety four E.coli TG1Tr colonies carrying phages were selected from this screening and
propagated. Supernatant phages were screened. Their dextran binding was determined by
indirect sandwich ELISA. Of ninety four phages selected by ELISA, 78% of them
showed no binding, 18% were 2 fold over control (A430 0.11) and 4% were more than 2.5
fold over control (Table 7). The phage producing highest absorbance (0.36) at 430 nm
was chosen and labeled M1114-89.
3.5. Selection by a Combination of ELISA Screening and Sephadex Column
A combination of ELISA screening and Sephadex column selection was used to
further enrich M1114-89 for dextran binding. Those phages selected by ELISA screening
were passed through sephadex columns. After propagation, dextran binding was
determined by indirect sandwich ELISA on culture supernatants. A second set of ninety
four phages, selected after a combination of ELISA screening and sephadex column,
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Figure 16. The effect of dextran size on detection using a paper-dip
assay. Phage (SD-3, 4.4 x 107 t.u./ml ) was tested to determine the effects of
dextran size. Horse radish peroxidase anti-M13 antibody conjugated and
TM BlueTM substrate produced blue color, which was scanned by
NucleoTech's (San Mateo, CA) NucleoVision scanning densitometry system
with GelExpert software. The error bars represent standard deviation of
triplicate experiments (n = 6). R2. The coefficient of determination
represents of how well the regression model predict the dependent variables
from the independent variables.
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Table 7. Determination of dextran binding affinity of phages obtained after ELISA
screening
Phage

Absorbance

(M1114-#)

1
2
3
4
6
7
8
9
10
11
12
13
14
16
17
18
19
20
21
23
27
28
29
30
31
32
33

Phage

Absorbance

(M1114-#)

0.13
0.16
0.20
0.22
0.18
0.25
0.21
0.26
0.23
0.34
0.17
0.12
0.13
0.12
0.13
0.21
0.16
0.15
0.20
0.18
0.14
0.13
0.20
0.17
0.17
0.14
0.16

34
35
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
54
55
56
57
58
59
60
61
62
63

Phage

Absorbance

(M1114-#)

0.18
0.20
0.20
0.26
0.12
0.13
0.23
0.19
0.17
0.30
0.16
0.26
0.19
0.18
0.12
0.14
0.12
0.16
0.17
0.16
0.16
0.21
0.23
0.13
0.15
0.20
0.14

64
65
67
69
70
71
73
74
75
76
77
78
79
80
81
82
83
84
85
87
88
*89
90
91
92
93
94

0.16
0.19
0.22
0.17
0.21
0.23
0.13
0.18
0.18
0.12
0.23
0.23
0.21
0.19
0.24
0.25
0.22
0.17
0.16
0.15
0.15
0.36
0.14
0.26
0.28
0.22
0.17

Bold numbers indicate phages showing 2.5 fold the absorbance (A430 > 0.27)
of the control and number *89 indicates phage (M1114-89) which produced
highest absorbance (0.36) at A430. The phages were propagated individually
from ninety four E.coli TG1Tr colonies. The control which does not contain
dextran showed less than 0.11 at A430. Phages with equal values to or below
control are not listed.
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were tested for dextran binding. These 53% were 2 fold over control (A430 0.11) and 29%
were more than 2.5 fold control (Table 8). A seven fold increase was seen in the
percentage of phages that produced an absorbance greater than 0.27 at 430nm (Table 9).
This indicates that those phages propagated from single colonies of E.coli TG1Tr were
mixtures of phages with different dextran binding affinities and that combination
screening improves the chances of selecting for the desired property. After combination
screening, phages (M1114-m74) screened with Sephadex bead-agarose electrophoresis
(SBAE).
3.6. Selection by Sephadex Bead-Agarose Electrophoresis (SBAE)
Selection of dextran binding phages by TLC, ELISA screening or Sephadex
columns is both time consuming, requiring repeated procedures and the selected phages
generally produce low color intensity on indirect sandwich ELISA. Screening using
Sephadex bead-agarose electrophoresis (SBAE) produced highly enriched phage
preparations, AE-M1114-m74-1R and AE-M1114-m74-2R after only two rounds. The
color intensity produced by AE-M1114-m74-2R, obtained after the 2nd round selection
was 3.5 times higher than that of phages AE-M1114-m74-1R obtained after the 1st round
selection and approximately 30 times higher than the starting phage (M1114-m74). AEM1114-m74-2R was used in the paper dip assay (Fig. 17) and all further work.
3.7. Indirect Sandwich ELISA for Dextran Analysis Using Phages
Detection of various concentration of dextran using indirect sandwich ELISA
with phages, M1114-m74 and AE-M1114-m74-2R, were tested. ELISA plate wells were
each coated with 200 µl of an anti-dextran polyclonal antibody (goat origin) and then 200
µl of various concentration of dextran solutions (T2000, 1.4, 6.3, 25, 100, and 200 µg)
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Table 8. Determination of dextran binding affinity of phages obtained after a
combination screening by ELISA and Sephadex column.
Phage

Absorbance

(M1114-m#)

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31

Phage

Absorbance

(M1114-m#)

0.28
0.27
0.27
0.25
0.25
0.22
0.20
0.20
0.18
0.18
0.18
0.25
0.27
0.27
0.28
0.27
0.25
0.25
0.21
0.20
0.17
0.19
0.17
0.19
0.28
0.28
0.27
0.27
0.23
0.24
0.21

32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62

Phage

Absorbance

(M1114-m#)

0.19
0.18
0.19
0.18
0.21
0.30
0.25
0.27
0.27
0.24
0.21
0.22
0.20
0.17
0.21
0.22
0.18
0.22
0.27
0.27
0.25
0.22
0.21
0.24
0.21
0.20
0.17
0.16
0.20
0.27
0.28

63
64
65
66
67
68
69
70
71
72
73
*74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
94

0.25
0.25
0.24
0.22
0.24
0.19
0.19
0.20
0.19
0.21
0.27
0.40
0.27
0.27
0.27
0.19
0.20
0.20
0.20
0.19
0.18
0.20
0.27
0.27
0.27
0.23
0.25
0.27
0.21
0.21
0.25

Bold numbers indicate phages showing 2.5 fold the absorbance (A430 > 0.27)
of the control and number *74 indicates phages (M1114-m74) which produced
the highest absorbance (0.40) at 430 nm. The phages were propagated
individually from the ninety four E.coli TG1Tr colonies tested. The control,
which does not contain dextran, showed less than 0.11 at A430. Phages with
equal values to or below control are not listed.
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Table 9. Comparison of a combination of ELISA screening and sephadex column
with ELISA screening for dextran binding phages.

Screening method

% Phages1 (A430 > 0.22)

% Phages2 (A430 > 0.27)

A single ELISA screening

22%

4%

A combination of ELISA
screening and Sephadex
column

54%

29%

Percentage of phages showing 2.01 or 2.52 fold higher absorbance increase than
control out of ninety four phages.
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Figure 17. Determination of dextran binding affinity using a paper dip assay of
phages, AE-M1114-m74-1R and 2R. Phage (AE-M1114-m74-1R and 2R, 105
t.u./ml) were tested to detect dextran (T2000, 1000ppm). Horse radish peroxidase antiM13 antibody conjugated and TM BlueTM substrate produced blue color, which was
scanned by NucleoTech's (San Mateo, CA) NucleoVision scanning densitometry
system with GelExpert software. The error bars represent standard deviation of
triplicate experiments. (A) A paper-dip assay using phages (AE-M1114-m74-1R and
2R, 105 t.u./ml) obtained after first and second round of Sephadex bead agarose
electrophoresis (SBAE) (B) Comparison of color densities of first and second round of
phages (AE-M1114-m74-1R and 2R) by a paper-dip assay. 1R-test (or control), 1st
round SBAE test (or control); 2R-test (or control), 2nd round SBAE test (or control).
The error bars represent standard deviation of triplicate experiments.
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were added and then phages were added to each well. Phages (10 5 t.u./ml)
showed saturation at 25 µg of dextran. The smallest amount of dextran detected was 6.3
µg. Phage (AE-M1114-m74-2R) produced the highest absorbance (A430 0.83) against 100
µg of dextran (T2000) (Fig. 18).
3.8. Transmission Electron Microscopy for Dextran Analysis
Dextran binding by the phage was confirmed by enumeration of phage on TEM
grids, which had been coated with anti-dextran monoclonal antibody and dextran (T10).
The grids were dipped in solution of AE-M1114-m74-2R or of the Fab 2lox library as a
control. Phages were quantitated by counting phages bound on 48 fields for each of 8
grids. Phages (AE-M1114-m74-2R) were distributed over the dextran coated grids with
39 ± 25 phages/µm2 on the grids (Fig. 19). Phages were not seen on dextran coated grids
exposed to phage library (Fig. 20). The small marks on the TEM photographs are uranyl
stain artifacts. They are also seen in the negative control grids.
3.9. Characterization of Phage AE-M1114-m74-2R
3.9.1. Effects of Dextran Size and Dextran Concentration. The effect of dextran
molecular size on binding of dextran by AE-M1114-m74 was determined for the paperdip format. High molecular size dextran (T10000, 107) produced the highest color
intensity (59 ±5), T2000 (2x106), 40 ±8 and T40 (4x104) showed the lowest intensity, 15
±1 (Fig. 21). As with phage SD3, there was a linear relationship (R2=0.9712) between
dextran size and color intensity.
Serial dilutions of dextran (T2000) solution were used to determine the detection
limits of phage (AE-M1114-m74-2R, 2.5 x105 t.u./ml). The phage produced 54±3 color
normalized intensity (N.I.) from 125 ppm to 1000 ppm of dextran and 5 ±1 (N.I) for 63
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Figure 18. Detection of dextran concentration with an indirect sandwich
ELISA. Dextran (1.4, 6.3, 25, 100, and 200 µg) was bound to the ELISA
plates coated with 200 µl of an anti-dextran polyclonal antibody and then the
presence of phages that bound to these dextran was determined using
horseradish peroxidase anti-M13 antibody conjugated and a substrate solution
(500 µg/ml 2,2’-azino-bis 3-ethylbenthiazoline-6-sulfonic acid, 4 µl of 30%
hydrogen peroxide in 12 ml of 0.1 M citrate buffer, pH 3.8) producing a blue
color and then plates were read using a SPECTRAmax Plus microtiter plate
reader (Molecular Devices Coporation, Sunnyvale, CA) at A430. The error
bars represent standard deviation of duplicate experiments (n = 4).
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(A)

Uranyl acetate staining

Phages bound to treated grid

(B)

Phages bound to treated grid

Figure 19. Transmission electron microscopy photograph of the phages (AE-M1114m74-2R) bound to dextran (T2000, 0.13 µg) coated grids. Grids were placed on the
drops (10 µl) of anti-dextran antibody diluted 1:500 with sterile distilled water for 5 min.
After washing twice with distilled water, they were placed on a drop (10 µl) of dextran
(T10, 500 ppm) dissolved in filtered water, air dried for 5 minutes, blotted with filter
paper, then touched to a 20 µl drop of phage solution and rinsed once in filtered water.
The grids were exposed to 50 µl of 2% uranyl acetate stain. Arrows indicate phages
bound to dextran on grids. The small dots are uranyl staining marks. The marker bar is 1
µm.
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(A)

Phages found in grid without dextran coating

(B)

Figure 20. Transmission electron microscopy photograph of Fab 2lox library. Grids
were placed on the drops (10 µl) of anti-dextran antibody diluted 1:500 with sterile
distilled water for 5 min. After washing twice with distilled water, grids were placed on
the drop (10 µl) of dextran (T10, 500 ppm) dissolved in filtered water, air dried for 5
minutes, blotted with filter paper to drain excess solution, then touched to a 20 µl drop
containing control Fab 2lox library and rinsed once in filtered water. The grids were
exposed to 50 µl of 2% uranyl acetate stain. Small dots are uranyl staining marks. The
marker bar is 1 µm.
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Figure 21. Effects of dextran molecular size on dextran binding.
The effect of dextran molecular size on dextran binding was determined for a paperdip assay with phage (AE-M1114-m74-2R, 105 t.u./ml). Horse radish peroxidase
conjugated anti-M13 antibody and TM BlueTM substrate were used to detect the
presence of phages bound to dextran adhere to the paper and the blue color was
scanned by NucleoVision scanning densitometry system. The error bars represent
standard deviations of triplicate experiments (n = 6). R2. The coefficient of
determination represents of how well the regression model predict the dependent
variables.
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ppm of dextran. The phage showed saturation below 125 ppm of dextran and 63 ppm of
test dextran solution produced the lowest dextran detection in this paper-dip assay (Fig.
22). This corresponded approximately to the visual detection limit.
3.9.2. Phage Antibody Concentration and Specificity Using Dip Stick Assay
Phage (AE-M1114-m74-2R) was serially diluted with PBS and the effects of
phage concentration on detection of dextran (T2000, 1000 ppm) on the paper-dip phageenzyme-linked assay were determined. Peak interesting was found at a phage
concentration of 6.5 x104. Above this level there was decreased N.I., possibly due to
blinding (Fig. 23). Any commercial application will have to take this into account.
Phage was tested for specificity against dextran, corn starch (Sigma, St. Louis,
MO), sucrose (Fisher Scientific, Fair Lawn, NJ), glucose (Fisher Scientific, Fair Lawn,
NJ), and chitin (Fisher Scientific, Fair Lawn, NJ) (Table 10). The N.I. for dextran was at
least 18 fold higher for the other carbohydrates. The negative control, PBS, produced an
N.I. of 3.5 ±5.
3.10. Application of the Paper-Dip Assay to Sugar Mills Samples
The paper-dip assay was used to detect dextran in mixed juices from four
Louisiana sugar mills. The results were compared to results obtained with the Midland
SucroTestTM (Fig. 24). Both assay methods were rapid and showed linear relationships
between dextran concentrations. Dextran concentrations above 50 ppm on sugar juices
were visually identified in the paper-dip assay, but only 10 ppm of dextran in solution
was required for detection with the Midland SucroTestTM. The Midland SucroTestTM was
approximately 5 fold more sensitive than the paper-dip assay. However, the paper dip
assay shows promise as a semi-quantitative rapid dextran method.
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Figure 22. Detection of dextran. Serial dilutions of dextran (T2000) solution
were prepared and the effects of dextran concentration on dextran binding were
determined by a paper-dip assay using phage (AE-M1114-m74-2R, 105 t.u./ml).
Horseradish peroxidase conjugated anti-M13 antibody and TM BlueTM substrate
were used to detect the presence of phages bound to dextran on the paper and a
developed blue color was scanned by NucleoVision scanning densitometry
system. The error bars represent standard deviations of triplicate experiments (n
= 6).
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Figure 23. Effect of phage concentration on dextran bound in a paper dip
assay. Phage (AE-M1114-m74-2R, 5 x 105 t.u./ml) diluted with PBS was used for
detection of dextran (T2000, 1000 ppm). Horse radish peroxidase conjugated antiM13 antibody and TM BlueTM substrate were used to detect the presence of phages
bound to dextran on the paper and a developed blue color was scanned by
NucleoVision scanning densitometry system. The error bars represent standard
deviations of triplicate experiments (n = 6).
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Table 10. Specificity of phage (AE-M1114-m74-2R) for polysaccharide
Carbohydrate

Standard deviation

Dextran

Normalized intensity
(N.I.)
27

Corn starch

6

8.5

Sucrose

1.5

2.1

Chitin

1.5

0.7

Glucose

6

8.5

PBS (Control)

3.5

4.9

7.1

Phage (AE-M1114-m74-2R, 105 t.u/ml) was tested for specificity against dextran (T2000,
1000 ppm), which was compared with 1000 ppm of other carbohydrates (corn starch,
sucrose, glucose, chitin). Phosphate buffered saline (PBS) was used as a control. Horse
radish peroxidase conjugated anti-M13 antibody and TM BlueTM substrate were used to
detect the presence of phages on the paper and a developed blue color was scanned by
NucleoVision scanning densitometry system. Standard deviations were obtained from
triplicate experiments (n = 6).
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Figure 24. Comparative detection of dextran in sugar juice between the
paper-dip assay and MCA-SucroTestTM. 1, 2, 3, and 4 represent samples
obtained at different sugar mills. Normalized intensity is the units from the
NucleoVision scanning densitometer. ∆Turbidity (NTU) is the unit of
immunonephelometric assay using anti-dextran polyclonal antibody.
The error bars represent standard deviations of triplicate experiments (n = 6).
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3.11. PCR Analysis of an Fab Insert in Phage Vector
Phage DNA expressing Fab fragments were amplified by PCR. Phage (AEM1114-m74-2R) DNA produced two bands, (2.1kb and 1.6kb) in 1% agarose gel (Fig.
25-A). The 1.6 kb bands are considered to be Fab DNA (Medical Research Council,
1995) and were cut out for purification. The purified DNA was separated on 1% agarose
gels by electrophoresis for confirmation of the presence of single bands and for heavy
chain DNA sequencing (Fig. 25-B).
3.12. Fab DNA Sequencing
The PCR products of both light chains (λ, κ) and the heavy chain from phage
(AE-M1114-m74-2R) were approximately 420 bp, 550 bp and 600 bp (Fig. 26-A and B).
The phage was found to display mixed antibodies with VH-Vκ and VH-Vλ as Fab inserts.
Cloning vectors (pCR® 2.1 TOPO®, Invitrogen, Carlsbad, CA) for the light chain inserts
(4 kappa chains and 3 lambda chains) were run on 1% agarose gel (Fig. 27-A) and
topoisomers were detected in the gel (Fig. 27-A). The presence of light chain inserts in
the cloning vector was confirmed by EcoRI enzyme digestion of the TOPO® cloning
vector with inserts. The lambda and kappa light chain DNA were 500 bp and 550 bp,
respectively (Fig. 27-B). Light chain and heavy chain were aligned to check homology
with human DNA sequences by BLAST search. Kappa chain showed a partial homology
(Expectation, E, value, 7e-08) with Homo sapiens immunoglobulin kappa locus,
proximal V-cluster and J-C cluster (IGK-proximal) on chromosome 2; Lambda chain
with Homo sapiens anti-rabies SO57 immunoglobulin lambda light chain mRNA (E= 2e3); and the heavy chain with Homo sapiens cDNA FLJ40046 fis, clone SYNOV2001300,
immunoglobulin heavy chain (E= 8e-08). The lambda chain homology was poor.
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Figure 25. PCR Analysis of Fab inserts in phage (AE-M1114-m74-2R).
(A) PCR confirmation of a Fab insert in phage (AE-M1114-m74-2R): Template DNA
was obtained from phage infected bacterial stocks using a Wizard Plus Mini-preps DNA
purification system (Promega). Fab DNA amplification was carried out at 94°C, with
5min for pre-soaking, followed by 30 cycles of 94°C, 1 min for denaturation, 60 °C, 1
min for annealing, 72°C, 1.5 min for extension and finished by incubation at 72 °C for
5min in 50 µl PCR reaction mixture using primer, Fdpcrback-1
(GCGATGGTTGTTGTCATT) and primer, Fdseq1 (CCTCATACAGAAAATTC), 5mM
of dNTP, 25 mM of MgCl2, Taq polymerase and Taq buffer. The PCR products were
separated by electrophoresis at 70 volts for 60 min on 0.8 % agarose gel using TAE
buffer. (B) 1.6 kb DNA obtained after agarose gel purification. M, lambda Hind III size
marker.
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Figure 26. PCR products of light (κ and λ) and heavy chains in phage (AE-M1114m74-2R) (A) Kappa (lane 1,2 and 3) and lambda light chain (lane 4, 5, and 6) PCR
products (B) Heavy chain PCR products (lane 1 and 2). M, 100 bp DNA ladder size
marker. DNA amplification was carried out at 94°C, with 5min for pre-soaking, followed
by 30 cycles of 94°C, 1 min for denaturation, 60 °C, 1 min for annealing, 72°C, 1.5 min
for extension and finished by incubation at 72 °C for 5min in 50 µl PCR reaction mixture
using primers, 5mM of dNTP, 25mM of MgCl2 (0 to 2 µl) , Taq polymerase and Taq
buffer.
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Figure 27. (A) Agarose gel electrophoresis of plasmid containing kappa and lambda
light chain DNA of phage, AE-M1114-m74-2R after gel purification DNA: Kappa
light chain (K1, K3, K4, and K7) and lambda light chain(L1, L2, and L3) and M, lambda
Hind III size marker. (B) Restriction enzyme analysis of the plasmid containing
kappa and lambda light chain DNA of phage, AE-M1114-m74-2R using EcoRI: K1,
Kappa light chain #1; L1, lambda light chain #1; M1, lambda Hind III size marker; M2,
100 bp DNA ladder size marker.
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4. DISCUSSION
Bacterial action on sucrose can produce dextran. Dextran produces a number of
significant problems during sugar production. Dextran can be found in sugar mill process
streams at greater than 5000 ppm on volume in juice and at higher than 750 ppm in raw
sugar. The presence of dextran in sugar process juices is normally indicative of stale
cane, as much of the dextran is generated in damaged plant (sugarcane) material. Stale
juice is immediately obvious as it requires more lime to raise the pH and longer heating
times for adequate clarification (Chung, 2000). If the dextran levels are high it may not
clarify. Dextran in syrups cause production losses due to increased viscosity, lowered
crystallization rate and changes in sugar shape, increasing losses on separation. Because
dextran in sugar is not removed by refining, financial penalties are imposed on the seller
of raw sugar for sugar containing dextran above 250 ppm (Clarke, et al., 1988). The
proper management of a sugar cane processing facility would benefit from targeted
exclusion of loads of stale cane from the process.
Current methods for determining dextran are either slow, generally affected by
the presence of other polysaccharides, require special instrumentation or have high per
analysis cost. This research was conducted to further the development of a simple
screening method suitable for determining dextran in each load of sugar cane delivered to
sugar factory. The factories currently sample each load of cane for sugar content and a
number of other parameters. A rapid, low cost method for dextran can be applied at this
point to screen loads of sugar cane prior to delivery to the mill yard. The use of an antidextran phage suitable for use in a simple assay format, such as a paper-dip stick was
targeted as an appropriate reagent for dextran analysis in this application.
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Phage display antibody is an efficient production system that provides an
alternative to standard antibody methodology. Phage display systems allow the omission
of animal immunization and hybridoma production in acquiring specific haptens.
Classical antibody production methods require specialized equipment and procedures and
normally use high-cost serum-containing media, all of which is unnecessary for phage
production using bacteria (Clackson, et al., 1991, Emanuel, et al., 2000 and Harrison, et
al., 1996). Phages displaying fusion proteins, or antibody fragments (Fab), have the
ability to bind epitopes, antigenic determinants (Harrison, et al., 1996). These phages can
be maintained in and produced by E.coli, simplifying production to fermentation. The
selection of specific antigens, as against tumor cells, virus, toxins and self antigens, with
this technology is also simpler than classical antibody technology (Emanuel, et al., 2000
and Itoh, et al., 2001). Phage display library sizes can be expanded to larger repertories
by combinatorial infection, chain shuffling and mutations. Increased library size provides
increased opportunity for selection of suitable haptens for non-immunogenic compounds
(Winter, et al., 1994). There are a few reported instances on the use of phage display
antibodies for carbohydrates detection. Phage displaying Fab or scFV, fused with capsid
protein, were used for detection of a rhamnogalacturonan, Samonella serotype B Opolysaccharide and of cancer cell related-carbohydrate antigens, including sialyl Lewisxx
and Lewisx (Deng, et al., 1994, Yamamoto, et al., 1999, and Williams, et al., 1996).
A phage library (Fab 2lox) was screened for dextran binding phages using five
different methods: thin layer chromatography (TLC), Sephadex column, enzyme-linked
immunosorbent assay (ELISA) screening, a combination of ELISA and Sephadex column
screening and a technique developed in the course of this research, Sephadex bead
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agarose electrophoresis (SBAE). The basis for TLC screening is that dextran binding
phages bind to dextran (T2000) adsorbed, as bands, on silica plates, preventing these
phages from moving beyond the dextran region. Only those phages (Silica 426) collected
from the dextran band closest to the origin, showed dextran binding activity in
immunonephelometric assays. A Sephadex column is an alternative to biopanning with
immunotubes, and was preferred because unmodified dextran is water soluble and will
not bind to immunotubes. Sephadex consists of beads of cross-linked dextran, which both
provide sites for anti-dextran phage binding and concurrently separate salts and small
impurities from the preparations. Immunonephelometric assays were used to determine
the dextran binding affinity of all new phage preparations (Silica 426, M710-1R and
M710-3R). The immunonephelometric assay measures turbidity by light scattering
caused by lattice formation between antigens and antibodies (Whicher, et al., 1983).
Phages, M710-3R, and Silica 416 showed increases greater than 21 fold over control
values after 60 min-reaction times. Day et al. (2002) reported that turbidity formation by
a mouse anti-dextran monoclonal antibody was concentration dependent, with the
reaction going to completion in 3 min at high antibody concentrations. The reaction rate
of phage antibody presumably was slow in comparison, because lower concentrations of
phage were used.
Six phage collections (SD-1, SD-2, SD-3, SD-4, SD-5, and SD-6) were enriched
by Sephadex column. They were from six different E.coli TG1Tr colonies that had been
infected with phage collection (M710-3R). They each produced different color densities
on paper chromatography, indicating that each one was a mixture with different dextran
binding capabilities. One, (SD-3), was selected for use in development of a paper-dip
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assay. Protein coated polyvinylidene difluoride membranes (PVDF) were dipped into
dextran solution (T2000) and dried at room temperature to use as the matrix.
Polyvinylidene difluoride membranes (PVDF) are recommended over cellulose acetate
membranes because PVDF is more efficient in blocking non-specific binding of antibody
on membranes (Dewey, et al., 1989). Test solution was applied to the membrane and
dried at room temperature. Then 5 µl of phage SD-3 was applied to the paper, incubated
for 1 min, washed once by dipping in 1% PBST (PBS + 1% Tween 20) and dried at room
temperature. One µl of a dilution (1: 10000) of HRP-anti-M13 in 5% MPBST (PBS + 1%
Tween 20 + 5% skim milk) was applied for 5 sec and then washed three times by dipping
into 1% PBST. TM BlueTM substrate (0.5 ml) was applied to develop color. The intensity
of the spots that was formed was determined using scanning densitometry. The
normalized intensity was calculated as scanned intensity divided by area of the blot. The
effects of the phage concentration, dextran concentration, and dextran size were
determined using this assay. This assay was independent of phage concentration between
4.4 x 105 t.u./ml and 4.4 x 107 t.u./ml. Saturation with dextran was achieved below 500
ppm of T2000, the normal intensities did not increase with concentration above 500 ppm
of dextran. Saturation of antigen on the polyvinylidene difluoride membranes (PVDF)
limits the upper range of the assay. The normalized intensity increased as the molecular
size of dextran increased because high molecular size dextran has more epitope sites that
can react with a paratope, antigen binding sites on antibodies, than low molecular size
dextran. The SD-3 phage was not stable on propagation, it required further selection.
Phages can lose their insert (Fab) during propagation and phages without insert propagate
rapidly, which enriches the population for those phages.
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Phage (M1114), a mixture of phages (Silica 426 and M710-3R) were screened for
dextran binding by ELISA and then further screened by sephadex column. ELISA
screening provides for selection by using dextran bound to a polyclonal antibody coated
on the plate wells in a Sandwich ELISA format. After ELISA screening, ninety four
E.coli TG1Tr colonies carrying phages were chosen and these phages propagated. The
dextran binding of each phage was determined by indirect sandwich ELISA. Four % of
the 94 phages produced greater than 2.5 fold more color than the control (A430 0.11).
Sephadex column screening of M1114-89 produced phages where 29% were more than
2.5 fold control (A430 0.11). This indicates that phages propagated from single colonies of
E.coli TG1Tr are mixtures of phages, each with different dextran binding affinities and
that combination screening improves the chances of selecting for the desired property.
The enriched population (M1114-m74) was then screened by sephadex bead-agarose
electrophoresis.
Sephadex bead-agarose electrophoresis (SBAE) provided a novel and simple
screening method to select and enrich for a high dextran binding phages. Steptovidin
attached beads or magnetic beads are commercially available to select specific protein
bound to a specific ligand such that this procedure can potentially be used for any
antigen. In SBAE, after incubation of antigen attached to beads (sephadex beads) with
phage, agarose gel electrophoresis is used to separate specific phages. Phages (AEM1114-m74-2R) selected by SBAE produced about 30 fold higher color intensities than
phages M1114-m74. A paper dip assay was performed using phage (AE-M1114-m742R). The intensity produced in paper-dip assay was again proportional to dextran
concentration as was seen with SD-3. Phages, AE-M1114-m74-2R showed high
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specificity against dextran but not corn starch, sucrose, glucose or chitin. Dextran
concentrations greater than 50 ppm in sugar juices could be visually detected using a
paper-dip assay.
Serologically specific electron microscopy was used for confirmation of phage
binding to dextran. Derrick et al. (1975) pioneered this technique for diagnosis of plant
viruses in corn. Maize mosaic virus, in extracts from corn, was quantitated on
serologically specific electron microscopy grids, with potato virus Y antiserum diluted
from 1:100 to 1:3,200,000. The highest number of the virus was found on grids with an
antiserum diluted between 1:100 and 1:1000. Phage (39±25 phages/µm2) bound to
dextran was quantitated on TEM grids coated with a goat anti-dextran antibody diluted
1:500. This dilution was found to produce a low background. Serologically specific TEM
was also found to be a useful diagnostic assay for the quantifying dextran binding phage.
Because the phages can easily lose the inserts after each round of selection, they
were checked for the presence of an Fab insert in the vector using a β-galactosidase assay
and polymerase chain reactio. If the lac DNA of a phage is interrupted by Fab DNA, the
defective β-galactosidase of the host E. coli, induced by IPTG, will not complement the
β-galactosidase fragment of the phage. The resulting cells infected with phage containing
Fab DNA will produce no color in a β-galactosidase assay (Messing, 1983). Antibody
inserts in the phage vector were confirmed by PCR using DNA templates from single
colony infected cells. The single colonies were plated on tetracycline containing media
and checked for deletion of the Fab DNA insert (Harrison, et al., 1996). The insert was
approximately 1.6 kb (Medical Research Council, 1995) and a 2.1 kb band was present
which probably contains phage cloning vector sequence.
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B-cells produce 100 millions of different antibodies by a combination of antibody
DNA and somatic hypermutation, which is introduced into rearranged immunoglobin
genes by point mutations during activation and proliferation. It provides diversity of
antibody genes. Antibody engineering used to construct gene libraries uses this somatic
hypermutation to produce a large number of antibodies. The human synthetic phage
antibody library (Fab 2lox) was constructed from gene repertoires of variable domains of
the heavy and light chains produced by PCR, which causes a high synthesis error rate in
all the CDRs through mutation, synthesis errors and PCR artifacts. This synthetic library
replaces CDRs with random sequences from synthetic oligonucleotides to express all
antigen binding fragments (Fab) (Breitling and Dubel, 1999). Therefore, DNA sequences
of phage inserts are matched partially with DNA of human origin antibodies. The
selected phages (AE-M1114-m74-2R) showed two formats of Fab (VH-Vκ and VH-Vλ)
and nucleotide sequence alignment analysis by BLAST search showed that the phages
(AE-M1114-m74-2R) contain human origin antibody DNA with two light chains (κ and
λ) and a heavy chain DNA.
For use of a paper-dip assay in sugar mills, mixed juice solutions needed to be
diluted with distilled water prior to assay because maximum detection limit of this assay
was 125 ppm of dextran (T2000). After dipping each test paper into a serially diluted
mixed juice samples and drying at room temperature, then 5 µl of phage solution
containing 6.5x104 to 5x105 t.u./ml was applied to the paper, incubated for 1 min, washed
once by dipping in 1% PBST (PBS + 1% Tween 20) and dried at room temperature. One
µl of a dilution (1: 10000) of HRP-anti-M13 in 5% MPBST (PBS + 1% Tween 20 + 5%
skim milk) was applied for 5 sec and then washed three times by dipping into 1% PBST.
80

TM BlueTM substrate (0.5 ml) was applied to develop color. The test strips were
compared to standard papers, which had previously been dipped into known dextran
solutions ranging from 0 to 125 ppm. Dextran concentration in mixed sugar juices was
estimated by multiplying the dilution factor of the sample paper by the concentration of
the standard paper that showed similar color intensity. The paper dip assay was used to
detect dextran in mixed juices from sugar mills. The results were compared to those
obtained with the Midland SucroTestTM. This test was used to analyze the dextran
contents in mixed juices from four different sugar mills of Louisiana, detecting greater
than 50 ppm of dextran on solids in juice and showed high correlation with Midland
SucroTestTM, which is a rapid test using an anti-dextran monoclonal antibody. The
paper-dip stick assay was specific to dextran. This system has the potential of becoming a
method that can be used for routine screening of incoming loads of sugar cane, as well as
this being a case study for the value of phage display technology in analytical method
development.
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APPENDIX A
NUCLEIC ACID SEQUENCES OF ANTI-DEXTRAN PHAGE ANTIBODY
(AE-M1114-m74-2R)
(A) Kappa light chain DNA sequences
5’GCACTTGACATCCAGATGACCCAGTCTCCATCCTCCCTTCCCAAAGTGTCTG
GTATCTGCAAATTCCCCCTTCAACTGCTCATCAGATGGCGTATTACTGTCAAA
AGTATAACAGTGCCAAGTTCGCCTGTCGTCTGGCTGAAAACCTGGCTGTCGCC
CAATATCTGGGTACGCGTGCCGCTGACCGAAATTCATCAGGGCGATTTCTCTC
CGCTGTTCCGCTATACGCTGGCGATTATGCTATTGGCGATAGGCGGGGCGTGG
CTGTTTATTCGTATCCAGAACCGACCGTTGGTCGATCTCGAACACACAGCCTT
GCAGGTTGGTAAAGGGATTATTCCGCCGCCGCTGCGTGAGTATGGCGCTTCG
GAGGTGCGTTCCGTTACCCGTGCCTTTAACCATATGGCGGCTGGTGTTAAGCA
ACTGGCGGATGACGCACGCTGCTGATGGCGGGGGTAAGTCACGACTTGCGCA
CGCCGCTGACGCGTATTCGCCTGGCGGACTAGATGGCAACGCCTCTGATGAG
CAAT3’
(B) Lambda light chain DNA sequences
5’GTGGCCTTGTTGGCTTGAAGCTTCTGATCCTCTCCTGCCGATCGGATCTGTG
TGGCGTACTGCCGGATGGTATGGCCGATCTCGCGGTGGACTACCTGCTCTACT
TTCCTGTTGGGTGCTTGTCTCATACCGGCGATTTCCGCTATTCTAATTATTATG
CGAATACCGGGAGCGAACATCACATCCAATTGTAGTTCCGATCGTATCGTGG
AGTACCCGCCCGGGCTTCCGTCAAAATGATCAATAGCCGATATGCTGCCTGTG
GATAGCAAGCGACGTCAATGCGAAAGTTTGAGATCCCTGATTTCACCCCCGA
TATTTGGTCATGACTTTCTGGCTCGATCCCCAAGAGATTTTTGATCTGTAGGA
AAGGAGATAAGAGTCACCTCGGGCGAAAGTTTCAAGCCACCAAGGCCCCAAC
ATAACGCTTCAAGCCAACAAGGCCAC3’
(C) Heavy chain DNA sequences
5’GGGTGGTGCCATGGCATTTACGACTGTTCGACGCCTTGTGGCAAGACGCGC
GCGCCGTTCGTGACACTTCATTGACAATTGAGCATGTTCATACGACACACAGT
GTATTACTGTGCAAGAGTGTAAGACTGGGGCCAAGGTACCCTGCCTCCACCA
AGGGCCCATCGAAGGTGGACAAGAAAGTTGAGCCCAAATCTTGTAACGTGGA
CTCGCATGCTTGCGTACATCCTGCTCTCGAGTTAAGTGGATCCACTGTCTACC
TCACCCGCACAGGTACACACAATGGCATGTATGGTTATGGATTCATACAAGA
ATACGATGACGTTATCCTACGACAAGTATGTGTGTTTTCGACACATGTTGTAA
ACACTGATGCGTGTGCAACAATCAGCACAGTATCACATGCAGTCATTGTGGT
GCGTGCGAGACCGACGCCCAAGACAGCACTGTGATGTGTCCACGGATAGTAT
AAGTGGCACTAATCTGTGAACTGACAAAGGTCTATACTGCGTCCACGACTAA
AATGTTTTGTGACTCGAAGTCTAGACGTAACAAGTAGACGTCTGCGACACGG
ACGACGAATCGAGCTCGCG3’
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APPENDIX B
DNA SEQUENCE ALIGNMENTS OF ANTI-DEXTRAN PHAGE ANTIBODY
(AE-M1114-m74-2R) BY BLAST SEARCH
(A) Kappa light chain DNA sequence alignments
Homo sapiens partial mRNA for immunoglobulin light chain variable, E= 2e-08
Query: 1
Sbjct: 4

gcacttgacatccagatgacccagtctccatcctccct 38
||||| ||||||||||||||||||||||||||||||||
gcactcgacatccagatgacccagtctccatcctccct 41

Homo sapiens immunoglobulin kappa locus, proximal V-cluster and J-C cluster
(IGK-proximal) on chromosome 2, E= 7e-08
Query: 6

tgacatccagatgacccagtctccatcctccct 38
|||||||||||||||||||||||||||||||||
Sbjct: 128022 tgacatccagatgacccagtctccatcctccct 128054
Query: 93

tattactgtcaaaagtataacagtgcc 119
|||||||||||||||||||||||||||
Sbjct: 128278 tattactgtcaaaagtataacagtgcc 128304

Homo sapiens BAC clone RP11-316G9 from 2, complete sequence, E= 7e-08
Query: 6

tgacatccagatgacccagtctccatcctccct 38
|||||||||||||||||||||||||||||||||
Sbjct: 182643 tgacatccagatgacccagtctccatcctccct 182611

(B) Lambda light chain DNA sequence alignments
Homo sapiens anti-rabies SO57 immunoglobulin lambda light chain mRNA
E = 2e-3
Query: 1

gtggccttgttggcttgaagc 21
|||||||||||||||||||||
Sbjct: 482 gtggccttgttggcttgaagc 462

Homo sapiens immunoglobulin lambda light chain C2 region (IGLC2) gene, E= 0.22
Query: 1

gtggccttgttggcttgaagct 22
||||||||||||||||||||||
Sbjct: 102 gtggccttgttggcttgaagct 81
Query: 427 gcttcaagccaacaaggccac 447
|||||||||||||||||||||
Sbjct: 82 gcttcaagccaacaaggccac 102
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(C) Heavy chain DNA sequence alignments
Homo sapiens cDNA clone MGC:39273 IMAGE:5440834, Expect = 8e-08
Query: 147 gcctccaccaagggcccatcg 167
|||||||||||||||||||||
Sbjct: 487 gcctccaccaagggcccatcg 507
Query: 168 aaggtggacaagaaagttgagcccaaatcttgt 200
|||||||||||||||||||||||||||||||||
Sbjct: 763 aaggtggacaagaaagttgagcccaaatcttgt 795

Homo sapiens cDNA FLJ40046 fis, clone SYNOV2001300, immunoglobulin heavy
chain, Expect = 8e-08
Query: 147 gcctccaccaagggcccatcg 167
|||||||||||||||||||||
Sbjct: 441 gcctccaccaagggcccatcg 461
Query: 168 aaggtggacaagaaagttgagcccaaatcttgt 200
|||||||||||||||||||||||||||||||||
Sbjct: 717 aaggtggacaagaaagttgagcccaaatcttgt 749

Homo sapiens IgH mRNA for anti-HBs antibody heavy chain, Expect = 8e-08
Query: 147 gcctccaccaagggcccatcg 167
|||||||||||||||||||||
Sbjct: 412 gcctccaccaagggcccatcg 432
Query: 168 aaggtggacaagaaagttgagcccaaatcttgt 200
|||||||||||||||||||||||||||||||||
Sbjct: 688 aaggtggacaagaaagttgagcccaaatcttgt 720
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APPENDIX C
QUANTIFICATION OF PHAGES, AE-M1114-m74 OR FAB 2LOX LIBRARY ON
TRANSMISSION ELECTRON MICROSCOPY GRIDS COATED WITH
DEXTRAN (T10)
Phages/ No. of µm2 Field

No. of Grid
1

2

3

4

5

6

7

1

40

80

64

57

85

77

67

2

6

12

12

10

12

11

11

3

34

66

20

43

36

22

42

4

32

11

23

46

33

74

66

5

0

0

0

0

0

6

0

0

0

0

0

7

0

0

0

0

0

8

0

0

0

0

0

Phages were counted on 28 fields of 4 grids (#1 – 4) or for Fab 2lox library, from 20
fields of 4 grids (#5 – 8).
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APPENDIX D
LETTER OF PERMISSION
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